<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nature</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nature</journal-id>
    <journal-title-group>
      <journal-title>Nature</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0028-0836</issn>
    <issn pub-type="epub">1476-4687</issn>
    <publisher>
      <publisher-name>Nature Publishing Group UK</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">4750478</article-id>
    <article-id pub-id-type="pmid">26432245</article-id>
    <article-id pub-id-type="publisher-id">BFnature15393</article-id>
    <article-id pub-id-type="doi">10.1038/nature15393</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>A global reference for human genetic variation</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <collab>The 1000 Genomes Project Consortium<contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Auton</surname><given-names>Adam</given-names></name><address><email>adam.auton@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Abecasis</surname><given-names>Gonçalo R.</given-names></name><address><email>goncalo@umich.edu</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><on-behalf-of>for the Corresponding authors</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Altshuler</surname><given-names>David M.</given-names><suffix>(Co-Chair)</suffix></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Durbin</surname><given-names>Richard M.</given-names><suffix>(Co-Chair)</suffix></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Abecasis</surname><given-names>Gonçalo R.</given-names></name><address><email>goncalo@umich.edu</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Bentley</surname><given-names>David R.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Chakravarti</surname><given-names>Aravinda</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Clark</surname><given-names>Andrew G.</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Donnelly</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="Aff8">8</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Eichler</surname><given-names>Evan E.</given-names></name><xref ref-type="aff" rid="Aff10">10</xref><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Flicek</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><name><surname>Gabriel</surname><given-names>Stacey B.</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name><surname>Gibbs</surname><given-names>Richard A.</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name><surname>Green</surname><given-names>Eric D.</given-names></name><xref ref-type="aff" rid="Aff15">15</xref></contrib><contrib contrib-type="author"><name><surname>Hurles</surname><given-names>Matthew E.</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Knoppers</surname><given-names>Bartha M.</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name><surname>Korbel</surname><given-names>Jan O.</given-names></name><xref ref-type="aff" rid="Aff12">12</xref><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><name><surname>Lander</surname><given-names>Eric S.</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Charles</given-names></name><xref ref-type="aff" rid="Aff18">18</xref><xref ref-type="aff" rid="Aff19">19</xref></contrib><contrib contrib-type="author"><name><surname>Lehrach</surname><given-names>Hans</given-names></name><xref ref-type="aff" rid="Aff20">20</xref><xref ref-type="aff" rid="Aff21">21</xref></contrib><contrib contrib-type="author"><name><surname>Mardis</surname><given-names>Elaine R.</given-names></name><xref ref-type="aff" rid="Aff22">22</xref></contrib><contrib contrib-type="author"><name><surname>Marth</surname><given-names>Gabor T.</given-names></name><xref ref-type="aff" rid="Aff23">23</xref></contrib><contrib contrib-type="author"><name><surname>McVean</surname><given-names>Gil A.</given-names></name><xref ref-type="aff" rid="Aff8">8</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Nickerson</surname><given-names>Deborah A.</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name><surname>Schmidt</surname><given-names>Jeanette P.</given-names></name><xref ref-type="aff" rid="Aff24">24</xref></contrib><contrib contrib-type="author"><name><surname>Sherry</surname><given-names>Stephen T.</given-names></name><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Jun</given-names></name><xref ref-type="aff" rid="Aff26">26</xref><xref ref-type="aff" rid="Aff27">27</xref><xref ref-type="aff" rid="Aff28">28</xref><xref ref-type="aff" rid="Aff29">29</xref><xref ref-type="aff" rid="Aff30">30</xref></contrib><contrib contrib-type="author"><name><surname>Wilson</surname><given-names>Richard K.</given-names></name><xref ref-type="aff" rid="Aff22">22</xref></contrib><on-behalf-of>for the Steering committee</on-behalf-of></contrib-group><contrib-group><on-behalf-of>for the Production group</on-behalf-of></contrib-group><contrib-group><on-behalf-of>for the Analysis group</on-behalf-of></contrib-group><contrib-group><on-behalf-of>for the Structural variation group</on-behalf-of></contrib-group><contrib-group><on-behalf-of>for the Exome group</on-behalf-of></contrib-group><contrib-group><on-behalf-of>for the Functional interpretation group</on-behalf-of></contrib-group><contrib-group><on-behalf-of>for the Chromosome Y group</on-behalf-of></contrib-group><contrib-group><on-behalf-of>for the Data coordination center group</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Chakravarti</surname><given-names>Aravinda</given-names><suffix>(Co-Chair)</suffix></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Knoppers</surname><given-names>Bartha M.</given-names><suffix>(Co-Chair)</suffix></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Abecasis</surname><given-names>Gonçalo R.</given-names></name><address><email>goncalo@umich.edu</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Barnes</surname><given-names>Kathleen C.</given-names></name><xref ref-type="aff" rid="Aff131">131</xref></contrib><contrib contrib-type="author"><name><surname>Beiswanger</surname><given-names>Christine</given-names></name><xref ref-type="aff" rid="Aff31">31</xref></contrib><contrib contrib-type="author"><name><surname>Burchard</surname><given-names>Esteban G.</given-names></name><xref ref-type="aff" rid="Aff80">80</xref></contrib><contrib contrib-type="author"><name><surname>Bustamante</surname><given-names>Carlos D.</given-names></name><xref ref-type="aff" rid="Aff65">65</xref></contrib><contrib contrib-type="author"><name><surname>Cai</surname><given-names>Hongyu</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name><surname>Cao</surname><given-names>Hongzhi</given-names></name><xref ref-type="aff" rid="Aff26">26</xref><xref ref-type="aff" rid="Aff27">27</xref></contrib><contrib contrib-type="author"><name><surname>Durbin</surname><given-names>Richard M.</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Gerry</surname><given-names>Norman P.</given-names></name><xref ref-type="aff" rid="Aff31">31</xref></contrib><contrib contrib-type="author"><name><surname>Gharani</surname><given-names>Neda</given-names></name><xref ref-type="aff" rid="Aff31">31</xref></contrib><contrib contrib-type="author"><name><surname>Gibbs</surname><given-names>Richard A.</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name><surname>Gignoux</surname><given-names>Christopher R.</given-names></name><xref ref-type="aff" rid="Aff80">80</xref></contrib><contrib contrib-type="author"><name><surname>Gravel</surname><given-names>Simon</given-names></name><xref ref-type="aff" rid="Aff54">54</xref></contrib><contrib contrib-type="author"><name><surname>Henn</surname><given-names>Brenna</given-names></name><xref ref-type="aff" rid="Aff132">132</xref></contrib><contrib contrib-type="author"><name><surname>Jones</surname><given-names>Danielle</given-names></name><xref ref-type="aff" rid="Aff44">44</xref></contrib><contrib contrib-type="author"><name><surname>Jorde</surname><given-names>Lynn</given-names></name><xref ref-type="aff" rid="Aff105">105</xref></contrib><contrib contrib-type="author"><name><surname>Kaye</surname><given-names>Jane S.</given-names></name><xref ref-type="aff" rid="Aff133">133</xref></contrib><contrib contrib-type="author"><name><surname>Keinan</surname><given-names>Alon</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Kent</surname><given-names>Alastair</given-names></name><xref ref-type="aff" rid="Aff134">134</xref></contrib><contrib contrib-type="author"><name><surname>Kerasidou</surname><given-names>Angeliki</given-names></name><xref ref-type="aff" rid="Aff135">135</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Yingrui</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name><surname>Mathias</surname><given-names>Rasika</given-names></name><xref ref-type="aff" rid="Aff136">136</xref></contrib><contrib contrib-type="author"><name><surname>McVean</surname><given-names>Gil A.</given-names></name><xref ref-type="aff" rid="Aff8">8</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Moreno-Estrada</surname><given-names>Andres</given-names></name><xref ref-type="aff" rid="Aff65">65</xref><xref ref-type="aff" rid="Aff69">69</xref></contrib><contrib contrib-type="author"><name><surname>Ossorio</surname><given-names>Pilar N.</given-names></name><xref ref-type="aff" rid="Aff137">137</xref><xref ref-type="aff" rid="Aff138">138</xref></contrib><contrib contrib-type="author"><name><surname>Parker</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="Aff135">135</xref></contrib><contrib contrib-type="author"><name><surname>Resch</surname><given-names>Alissa M.</given-names></name><xref ref-type="aff" rid="Aff31">31</xref></contrib><contrib contrib-type="author"><name><surname>Rotimi</surname><given-names>Charles N.</given-names></name><xref ref-type="aff" rid="Aff139">139</xref></contrib><contrib contrib-type="author"><name><surname>Royal</surname><given-names>Charmaine D.</given-names></name><xref ref-type="aff" rid="Aff140">140</xref></contrib><contrib contrib-type="author"><name><surname>Sandoval</surname><given-names>Karla</given-names></name><xref ref-type="aff" rid="Aff65">65</xref></contrib><contrib contrib-type="author"><name><surname>Su</surname><given-names>Yeyang</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name><surname>Sudbrak</surname><given-names>Ralf</given-names></name><xref ref-type="aff" rid="Aff32">32</xref></contrib><contrib contrib-type="author"><name><surname>Tian</surname><given-names>Zhongming</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name><surname>Tishkoff</surname><given-names>Sarah</given-names></name><xref ref-type="aff" rid="Aff141">141</xref></contrib><contrib contrib-type="author"><name><surname>Toji</surname><given-names>Lorraine H.</given-names></name><xref ref-type="aff" rid="Aff31">31</xref></contrib><contrib contrib-type="author"><name><surname>Tyler-Smith</surname><given-names>Chris</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Via</surname><given-names>Marc</given-names></name><xref ref-type="aff" rid="Aff142">142</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yuhong</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Huanming</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Ling</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name><surname>Zhu</surname><given-names>Jiayong</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><on-behalf-of>for the Samples and ELSI group</on-behalf-of></contrib-group><contrib-group><on-behalf-of>for the Sample collection</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Brooks</surname><given-names>Lisa D.</given-names></name><xref ref-type="aff" rid="Aff166">166</xref></contrib><contrib contrib-type="author"><name><surname>Felsenfeld</surname><given-names>Adam L.</given-names></name><xref ref-type="aff" rid="Aff166">166</xref></contrib><contrib contrib-type="author"><name><surname>McEwen</surname><given-names>Jean E.</given-names></name><xref ref-type="aff" rid="Aff166">166</xref></contrib><contrib contrib-type="author"><name><surname>Vaydylevich</surname><given-names>Yekaterina</given-names></name><xref ref-type="aff" rid="Aff166">166</xref></contrib><contrib contrib-type="author"><name><surname>Green</surname><given-names>Eric D.</given-names></name><xref ref-type="aff" rid="Aff15">15</xref></contrib><contrib contrib-type="author"><name><surname>Duncanson</surname><given-names>Audrey</given-names></name><xref ref-type="aff" rid="Aff167">167</xref></contrib><contrib contrib-type="author"><name><surname>Dunn</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="Aff167">167</xref></contrib><contrib contrib-type="author"><name><surname>Schloss</surname><given-names>Jeffery A.</given-names></name><xref ref-type="aff" rid="Aff166">166</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Jun</given-names></name><xref ref-type="aff" rid="Aff26">26</xref><xref ref-type="aff" rid="Aff27">27</xref><xref ref-type="aff" rid="Aff28">28</xref><xref ref-type="aff" rid="Aff29">29</xref><xref ref-type="aff" rid="Aff30">30</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Huanming</given-names></name><xref ref-type="aff" rid="Aff26">26</xref><xref ref-type="aff" rid="Aff168">168</xref></contrib><on-behalf-of>for the Scientific management</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Auton</surname><given-names>Adam</given-names></name><address><email>adam.auton@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Brooks</surname><given-names>Lisa D.</given-names></name><xref ref-type="aff" rid="Aff166">166</xref></contrib><contrib contrib-type="author"><name><surname>Durbin</surname><given-names>Richard M.</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Garrison</surname><given-names>Erik P.</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Min Kang</surname><given-names>Hyun</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Korbel</surname><given-names>Jan O.</given-names></name><xref ref-type="aff" rid="Aff12">12</xref><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><name><surname>Marchini</surname><given-names>Jonathan L.</given-names></name><xref ref-type="aff" rid="Aff8">8</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>McCarthy</surname><given-names>Shane</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>McVean</surname><given-names>Gil A.</given-names></name><xref ref-type="aff" rid="Aff8">8</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Abecasis</surname><given-names>Gonçalo R.</given-names></name><address><email>goncalo@umich.edu</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><on-behalf-of>for the Writing group</on-behalf-of></contrib-group></collab>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.251993.5</institution-id><institution-id institution-id-type="ISNI">0000000121791997</institution-id><institution>Department of Genetics, </institution><institution>Albert Einstein College of Medicine, </institution></institution-wrap>Bronx, 10461 New York USA </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution-id institution-id-type="ISNI">0000000086837370</institution-id><institution>Center for Statistical Genetics, Biostatistics, University of Michigan, </institution></institution-wrap>Ann Arbor, 48109 Michigan USA </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.422219.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 0384 7506</institution-id><institution>Vertex Pharmaceuticals, </institution></institution-wrap>Boston, 02210 Massachusetts USA </aff>
      <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.10306.34</institution-id><institution-id institution-id-type="ISNI">0000 0004 0606 5382</institution-id><institution>Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, </institution></institution-wrap>Cambridge, CB10 1SA UK </aff>
      <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.434747.7</institution-id><institution>Illumina United Kingdom, Chesterford Research Park, Little Chesterford, Nr Saffron Walden, </institution></institution-wrap>CB10 1XL Essex UK </aff>
      <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.21107.35</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9311</institution-id><institution>McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, </institution></institution-wrap>Baltimore, 21205 Maryland USA </aff>
      <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.5386.8</institution-id><institution-id institution-id-type="ISNI">000000041936877X</institution-id><institution>Center for Comparative and Population Genomics, Cornell University, </institution></institution-wrap>Ithaca, 14850 New York USA </aff>
      <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.270683.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 0641 4511</institution-id><institution>Wellcome Trust Centre for Human Genetics, University of Oxford, </institution></institution-wrap>Oxford, OX3 7BN UK </aff>
      <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.4991.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8948</institution-id><institution>Department of Statistics, </institution><institution>University of Oxford, </institution></institution-wrap>Oxford, OX1 3TG UK </aff>
      <aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.34477.33</institution-id><institution-id institution-id-type="ISNI">0000000122986657</institution-id><institution>Department of Genome Sciences, </institution><institution>University of Washington School of Medicine, </institution></institution-wrap>Seattle, 98195 Washington USA </aff>
      <aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="GRID">grid.34477.33</institution-id><institution-id institution-id-type="ISNI">0000000122986657</institution-id><institution>Howard Hughes Medical Institute, University of Washington, </institution></institution-wrap>Seattle, 98195 Washington USA </aff>
      <aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="GRID">grid.225360.0</institution-id><institution-id institution-id-type="ISNI">0000 0000 9709 7726</institution-id><institution>European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, </institution></institution-wrap>Cambridge, CB10 1SD UK </aff>
      <aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="GRID">grid.66859.34</institution-id><institution>The Broad Institute of MIT and Harvard, </institution></institution-wrap>7 Cambridge Center, Cambridge, 02142 Massachusetts USA </aff>
      <aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="GRID">grid.39382.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2160 926X</institution-id><institution>Baylor College of Medicine, Human Genome Sequencing Center, </institution></institution-wrap>Houston, 77030 Texas USA </aff>
      <aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="GRID">grid.280128.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2233 9230</institution-id><institution>US National Institutes of Health, National Human Genome Research Institute, </institution></institution-wrap>31 Center Drive, Bethesda, 20892 Maryland USA </aff>
      <aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="GRID">grid.14709.3b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8649</institution-id><institution>Centre of Genomics and Policy, McGill University, </institution></institution-wrap>Montreal, H3A 1A4 Quebec Canada </aff>
      <aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="GRID">grid.4709.a</institution-id><institution-id institution-id-type="ISNI">0000 0004 0495 846X</institution-id><institution>European Molecular Biology Laboratory, Genome Biology Research Unit, </institution></institution-wrap>Meyerhofstr. 1, Heidelberg, Germany </aff>
      <aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="GRID">grid.249880.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0374 0039</institution-id><institution>The Jackson Laboratory for Genomic Medicine, </institution></institution-wrap>10 Discovery Drive, Farmington, 06032 Connecticut USA </aff>
      <aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="GRID">grid.255649.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 7754</institution-id><institution>Department of Life Sciences, </institution><institution>Ewha Womans University, Ewhayeodae-gil, Seodaemun-gu, Seoul, </institution></institution-wrap>South Korea, 120-750 </aff>
      <aff id="Aff20"><label>20</label><institution-wrap><institution-id institution-id-type="GRID">grid.419538.2</institution-id><institution-id institution-id-type="ISNI">0000 0000 9071 0620</institution-id><institution>Max Planck Institute for Molecular Genetics, D-14195 Berlin-Dahlem, </institution></institution-wrap>Germany </aff>
      <aff id="Aff21"><label>21</label>Dahlem Centre for Genome Research and Medical Systems Biology, D-14195 Berlin-Dahlem, Germany </aff>
      <aff id="Aff22"><label>22</label><institution-wrap><institution-id institution-id-type="GRID">grid.4367.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2355 7002</institution-id><institution>McDonnell Genome Institute at Washington University, Washington University School of Medicine, </institution></institution-wrap>St Louis, 63108 Missouri USA </aff>
      <aff id="Aff23"><label>23</label><institution-wrap><institution-id institution-id-type="GRID">grid.223827.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2193 0096</institution-id><institution>USTAR Center for Genetic Discovery &amp; Department of Human Genetics, </institution><institution>University of Utah School of Medicine, </institution></institution-wrap>Salt Lake City, 84112 Utah USA </aff>
      <aff id="Aff24"><label>24</label><institution-wrap><institution-id institution-id-type="GRID">grid.417703.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 0462 4726</institution-id><institution>Affymetrix, Santa Clara, </institution></institution-wrap>California, 95051 USA </aff>
      <aff id="Aff25"><label>25</label><institution-wrap><institution-id institution-id-type="GRID">grid.94365.3d</institution-id><institution-id institution-id-type="ISNI">0000 0001 2297 5165</institution-id><institution>US National Institutes of Health, National Center for Biotechnology Information, </institution></institution-wrap>45 Center Drive, Bethesda, 20892 Maryland USA </aff>
      <aff id="Aff26"><label>26</label><institution-wrap><institution-id institution-id-type="GRID">grid.21155.32</institution-id><institution-id institution-id-type="ISNI">0000 0001 2034 1839</institution-id><institution>BGI-Shenzhen, </institution></institution-wrap>Shenzhen 518083, China </aff>
      <aff id="Aff27"><label>27</label><institution-wrap><institution-id institution-id-type="GRID">grid.5254.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 0674 042X</institution-id><institution>Department of Biology, </institution><institution>University of Copenhagen, </institution></institution-wrap>Ole Maaløes Vej 5, Copenhagen, 2200 Denmark </aff>
      <aff id="Aff28"><label>28</label><institution-wrap><institution-id institution-id-type="GRID">grid.412125.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 0619 1117</institution-id><institution>Princess Al Jawhara Albrahim Center of Excellence in the Research of Hereditary Disorders, King Abdulaziz University, </institution></institution-wrap>Jeddah, 80205 Saudi Arabia </aff>
      <aff id="Aff29"><label>29</label><institution-wrap><institution-id institution-id-type="GRID">grid.259384.1</institution-id><institution-id institution-id-type="ISNI">0000 0000 8945 4455</institution-id><institution>Macau University of Science and Technology, Avenida Wai long, </institution></institution-wrap>Taipa, 999078 Macau China </aff>
      <aff id="Aff30"><label>30</label><institution-wrap><institution-id institution-id-type="GRID">grid.194645.b</institution-id><institution-id institution-id-type="ISNI">0000000121742757</institution-id><institution>Department of Medicine and State Key Laboratory of Pharmaceutical Biotechnology, </institution><institution>University of Hong Kong, </institution></institution-wrap>21 Sassoon Road, Hong Kong </aff>
      <aff id="Aff31"><label>31</label><institution-wrap><institution-id institution-id-type="GRID">grid.282012.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 0627 5048</institution-id><institution>Coriell Institute for Medical Research, </institution></institution-wrap>Camden, 08103 New Jersey USA </aff>
      <aff id="Aff32"><label>32</label><institution-wrap><institution-id institution-id-type="GRID">grid.5012.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 0481 6099</institution-id><institution>European Centre for Public Heath Genomics, UNU-MERIT, Maastricht University, </institution></institution-wrap>PO Box 616, Maastricht, 6200 MD The Netherlands </aff>
      <aff id="Aff33"><label>33</label><institution-wrap><institution-id institution-id-type="GRID">grid.473915.d</institution-id><institution>Alacris Theranostics, D-14195 Berlin-Dahlem, </institution></institution-wrap>Germany </aff>
      <aff id="Aff34"><label>34</label><institution-wrap><institution-id institution-id-type="GRID">grid.459934.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 4658 1277</institution-id><institution>Personalis, Menlo Park, </institution></institution-wrap>California, 94025 USA </aff>
      <aff id="Aff35"><label>35</label><institution-wrap><institution-id institution-id-type="GRID">grid.280128.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2233 9230</institution-id><institution>US National Institutes of Health, National Human Genome Research Institute, </institution></institution-wrap>50 South Drive, Bethesda, 20892 Maryland USA </aff>
      <aff id="Aff36"><label>36</label><institution-wrap><institution-id institution-id-type="GRID">grid.18376.3b</institution-id><institution-id institution-id-type="ISNI">0000 0001 0723 2427</institution-id><institution>Department of Computer Engineering, </institution><institution>Bilkent University, </institution></institution-wrap>Bilkent, TR-06800 Ankara Turkey </aff>
      <aff id="Aff37"><label>37</label><institution-wrap><institution-id institution-id-type="GRID">grid.492568.4</institution-id><institution>Seven Bridges Genomics, </institution></institution-wrap>1 Broadway, 14th floor, Cambridge, 02142 Massachusetts USA </aff>
      <aff id="Aff38"><label>38</label><institution-wrap><institution-id institution-id-type="GRID">grid.36567.31</institution-id><institution-id institution-id-type="ISNI">0000 0001 0737 1259</institution-id><institution>Department of Agronomy, </institution><institution>Kansas State University, </institution></institution-wrap>Manhattan, 66506 Kansas USA </aff>
      <aff id="Aff39"><label>39</label><institution-wrap><institution-id institution-id-type="GRID">grid.185669.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0507 3954</institution-id><institution>Illumina, </institution></institution-wrap>San Diego, 92122 California USA </aff>
      <aff id="Aff40"><label>40</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Department of Genetics, </institution><institution>Harvard Medical School, </institution></institution-wrap>Cambridge, 02142 Massachusetts USA </aff>
      <aff id="Aff41"><label>41</label>SynapDx, Four Hartwell Place, Lexington, 02421 Massachusetts USA </aff>
      <aff id="Aff42"><label>42</label><institution-wrap><institution-id institution-id-type="GRID">grid.225279.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 0387 3667</institution-id><institution>Cold Spring Harbor Laboratory, Cold Spring Harbor, </institution></institution-wrap>New York, 11724 USA </aff>
      <aff id="Aff43"><label>43</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Seaver Autism Center and Department of Psychiatry, </institution><institution>Mount Sinai School of Medicine, </institution></institution-wrap>New York, 10029 New York USA </aff>
      <aff id="Aff44"><label>44</label><institution-wrap><institution-id institution-id-type="GRID">grid.5386.8</institution-id><institution-id institution-id-type="ISNI">000000041936877X</institution-id><institution>Department of Biological Statistics and Computational Biology, </institution><institution>Cornell University, </institution></institution-wrap>Ithaca, 14853 New York USA </aff>
      <aff id="Aff45"><label>45</label><institution-wrap><institution-id institution-id-type="GRID">grid.5386.8</institution-id><institution-id institution-id-type="ISNI">000000041936877X</institution-id><institution>Department of Genetic Medicine, </institution><institution>Weill Cornell Medical College, </institution></institution-wrap>New York, 10044 New York USA </aff>
      <aff id="Aff46"><label>46</label><institution-wrap><institution-id institution-id-type="GRID">grid.4709.a</institution-id><institution-id institution-id-type="ISNI">0000 0004 0495 846X</institution-id><institution>European Molecular Biology Laboratory, Genomics Core Facility, </institution></institution-wrap>Meyerhofstrasse 1, Heidelberg, 69117 Germany </aff>
      <aff id="Aff47"><label>47</label><institution-wrap><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution>Bill Lyons Informatics Centre, UCL Cancer Institute, University College London, </institution></institution-wrap>London, WC1E 6DD UK </aff>
      <aff id="Aff48"><label>48</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Center for Systems Biology and Department of Organismic and Evolutionary Biology, </institution><institution>Harvard University, </institution></institution-wrap>Cambridge, 02138 Massachusetts USA </aff>
      <aff id="Aff49"><label>49</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Department of Organismic and Evolutionary Biology, </institution><institution>Harvard University, </institution></institution-wrap>Cambridge, 02138 Massachusetts USA </aff>
      <aff id="Aff50"><label>50</label><institution-wrap><institution-id institution-id-type="GRID">grid.5600.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 0807 5670</institution-id><institution>Institute of Medical Genetics, School of Medicine, Cardiff University, Heath Park, </institution></institution-wrap>Cardiff, CF14 4XN UK </aff>
      <aff id="Aff51"><label>51</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Icahn School of Medicine at Mount Sinai, </institution></institution-wrap>One Gustave L. Levy Place, Box 1498, New York, 10029-6574 New York USA </aff>
      <aff id="Aff52"><label>52</label><institution-wrap><institution-id institution-id-type="GRID">grid.64337.35</institution-id><institution-id institution-id-type="ISNI">0000 0001 0662 7451</institution-id><institution>Department of Biological Sciences, </institution><institution>Louisiana State University, </institution></institution-wrap>Baton Rouge, 70803 Louisiana USA </aff>
      <aff id="Aff53"><label>53</label><institution-wrap><institution-id institution-id-type="GRID">grid.32224.35</institution-id><institution-id institution-id-type="ISNI">0000 0004 0386 9924</institution-id><institution>Analytic and Translational Genetics Unit, Massachusetts General Hospital, </institution></institution-wrap>Boston, 02114 Massachusetts USA </aff>
      <aff id="Aff54"><label>54</label><institution-wrap><institution-id institution-id-type="GRID">grid.411640.6</institution-id><institution>McGill University and Genome Quebec Innovation Centre, </institution></institution-wrap>740, Avenue du Dr. Penfield, Montreal, H3A 0G1 Quebec Canada </aff>
      <aff id="Aff55"><label>55</label><institution-wrap><institution-id institution-id-type="GRID">grid.280030.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 2150 6316</institution-id><institution>National Eye Institute, National Institutes of Health, </institution></institution-wrap>Bethesda, 20892 Maryland USA </aff>
      <aff id="Aff56"><label>56</label><institution-wrap><institution-id institution-id-type="GRID">grid.429884.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1791 0895</institution-id><institution>New York Genome Center, </institution></institution-wrap>101 Avenue of the Americas, 7th floor, New York, 10013 New York USA </aff>
      <aff id="Aff57"><label>57</label><institution-wrap><institution-id institution-id-type="GRID">grid.21729.3f</institution-id><institution-id institution-id-type="ISNI">0000000419368729</institution-id><institution>Department of Systems Biology, </institution><institution>Columbia University, </institution></institution-wrap>New York, 10032 NY USA </aff>
      <aff id="Aff58"><label>58</label><institution-wrap><institution-id institution-id-type="GRID">grid.21729.3f</institution-id><institution-id institution-id-type="ISNI">0000000419368729</institution-id><institution>Department of Computer Science, </institution><institution>Fu Foundation School of Engineering, Columbia University, </institution></institution-wrap>New York, New York USA </aff>
      <aff id="Aff59"><label>59</label><institution-wrap><institution-id institution-id-type="GRID">grid.413735.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 0475 2760</institution-id><institution>Harvard–MIT Division of Health Sciences and Technology, </institution></institution-wrap>Cambridge, 02139 Massachusetts USA </aff>
      <aff id="Aff60"><label>60</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>General Hospital and Harvard Medical School, </institution></institution-wrap>Boston, 02114 Massachusetts USA </aff>
      <aff id="Aff61"><label>61</label><institution-wrap><institution-id institution-id-type="GRID">grid.116068.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 2341 2786</institution-id><institution>Whitehead Institute for Biomedical Research, Nine Cambridge Center, </institution></institution-wrap>Cambridge, 02142 Massachusetts USA </aff>
      <aff id="Aff62"><label>62</label><institution-wrap><institution-id institution-id-type="GRID">grid.419890.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 0626 690X</institution-id><institution>Ontario Institute for Cancer Research, MaRS Centre, </institution></institution-wrap>661 University Avenue, Suite 510, Toronto, M5G 0A3 Ontario Canada </aff>
      <aff id="Aff63"><label>63</label><institution-wrap><institution-id institution-id-type="GRID">grid.29857.31</institution-id><institution-id institution-id-type="ISNI">0000 0001 2097 4281</institution-id><institution>Department of Anthropology, </institution><institution>Penn State University, University Park, </institution></institution-wrap>Pennsylvania, 16802 USA </aff>
      <aff id="Aff64"><label>64</label><institution-wrap><institution-id institution-id-type="GRID">grid.430387.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8796</institution-id><institution>Rutgers Cancer Institute of New Jersey, </institution></institution-wrap>New Brunswick, 08903 New Jersey USA </aff>
      <aff id="Aff65"><label>65</label><institution-wrap><institution-id institution-id-type="GRID">grid.168010.e</institution-id><institution-id institution-id-type="ISNI">0000000419368956</institution-id><institution>Department of Genetics, </institution><institution>Stanford University, </institution></institution-wrap>Stanford, 94305 California USA </aff>
      <aff id="Aff66"><label>66</label><institution-wrap><institution-id institution-id-type="GRID">grid.168010.e</institution-id><institution-id institution-id-type="ISNI">0000000419368956</institution-id><institution>Departments of Genetics and Pathology, </institution><institution>Stanford University, </institution></institution-wrap>Stanford, 94305-5324 California USA </aff>
      <aff id="Aff67"><label>67</label>Ancestry.com, San Francisco, 94107 California USA </aff>
      <aff id="Aff68"><label>68</label><institution-wrap><institution-id institution-id-type="GRID">grid.511991.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 4910 5831</institution-id><institution>DNAnexus, </institution></institution-wrap>1975 West El Camino Real STE 101, Mountain View California, 94040 USA </aff>
      <aff id="Aff69"><label>69</label><institution-wrap><institution-id institution-id-type="GRID">grid.418275.d</institution-id><institution-id institution-id-type="ISNI">0000 0001 2165 8782</institution-id><institution>Laboratorio Nacional de Genómica para la Biodiversidad (LANGEBIO), CINVESTAV, </institution></institution-wrap>Irapuato, 36821 Guanajuato Mexico </aff>
      <aff id="Aff70"><label>70</label><institution-wrap><institution-id institution-id-type="GRID">grid.12136.37</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0546</institution-id><institution>Blavatnik School of Computer Science, Tel-Aviv University, </institution></institution-wrap>Tel-Aviv, 69978 Israel </aff>
      <aff id="Aff71"><label>71</label><institution-wrap><institution-id institution-id-type="GRID">grid.12136.37</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0546</institution-id><institution>Department of Microbiology, </institution><institution>Tel-Aviv University, </institution></institution-wrap>Tel-Aviv, 69978 Israel </aff>
      <aff id="Aff72"><label>72</label><institution-wrap><institution-id institution-id-type="GRID">grid.185107.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2288 2137</institution-id><institution>International Computer Science Institute, </institution></institution-wrap>Berkeley, 94704 California USA </aff>
      <aff id="Aff73"><label>73</label><institution-wrap><institution-id institution-id-type="GRID">grid.418190.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 2187 0556</institution-id><institution>Thermo Fisher Scientific, </institution></institution-wrap>200 Oyster Point Boulevard, South San Francisco, 94080 California USA </aff>
      <aff id="Aff74"><label>74</label><institution-wrap><institution-id institution-id-type="GRID">grid.250942.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 0507 3225</institution-id><institution>The Translational Genomics Research Institute, </institution></institution-wrap>Phoenix, 85004 Arizona USA </aff>
      <aff id="Aff75"><label>75</label><institution-wrap><institution-id institution-id-type="GRID">grid.418190.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 2187 0556</institution-id><institution>Life Technologies, </institution></institution-wrap>Beverly, 01915 Massachusetts USA </aff>
      <aff id="Aff76"><label>76</label><institution-wrap><institution-id institution-id-type="GRID">grid.19006.3e</institution-id><institution-id institution-id-type="ISNI">0000 0000 9632 6718</institution-id><institution>Department of Human Genetics, </institution><institution>David Geffen School of Medicine at UCLA, </institution></institution-wrap>Los Angeles, 90024 California USA </aff>
      <aff id="Aff77"><label>77</label><institution-wrap><institution-id institution-id-type="GRID">grid.266100.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2107 4242</institution-id><institution>Department of Psychiatry, </institution><institution>University of California, </institution></institution-wrap>San Diego, La Jolla, 92093 California USA </aff>
      <aff id="Aff78"><label>78</label><institution-wrap><institution-id institution-id-type="GRID">grid.266100.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2107 4242</institution-id><institution>Department of Cellular and Molecular Medicine, </institution><institution>University of California, </institution></institution-wrap>San Diego, La Jolla, 92093 California USA </aff>
      <aff id="Aff79"><label>79</label><institution-wrap><institution-id institution-id-type="GRID">grid.251993.5</institution-id><institution-id institution-id-type="ISNI">0000000121791997</institution-id><institution>Department of Epidemiology and Population Health, </institution><institution>Albert Einstein College of Medicine, </institution></institution-wrap>Bronx, 10461 New York USA </aff>
      <aff id="Aff80"><label>80</label><institution-wrap><institution-id institution-id-type="GRID">grid.266102.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2297 6811</institution-id><institution>Departments of Bioengineering and Therapeutic Sciences, </institution><institution>University of California, </institution></institution-wrap>San Francisco, California, 94158 San Francisco USA </aff>
      <aff id="Aff81"><label>81</label><institution-wrap><institution-id institution-id-type="GRID">grid.266102.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2297 6811</institution-id><institution>Institute for Quantitative Biosciences (QB3), University of California, San Francisco, </institution></institution-wrap>1700 4th Street, San Francisco, 94158 California USA </aff>
      <aff id="Aff82"><label>82</label><institution-wrap><institution-id institution-id-type="GRID">grid.266102.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2297 6811</institution-id><institution>Institute for Human Genetics, University of California, San Francisco, </institution></institution-wrap>1700 4th Street, San Francisco, 94158 California USA </aff>
      <aff id="Aff83"><label>83</label><institution-wrap><institution-id institution-id-type="GRID">grid.205975.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0740 6917</institution-id><institution>Center for Biomolecular Science and Engineering, University of California, </institution></institution-wrap>Santa Cruz, Santa Cruz, 95064 California USA </aff>
      <aff id="Aff84"><label>84</label><institution-wrap><institution-id institution-id-type="GRID">grid.413575.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2167 1581</institution-id><institution>Howard Hughes Medical Institute, </institution></institution-wrap>Santa Cruz, 95064 California USA </aff>
      <aff id="Aff85"><label>85</label><institution-wrap><institution-id institution-id-type="GRID">grid.170205.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7822</institution-id><institution>Department of Human Genetics, </institution><institution>University of Chicago, </institution></institution-wrap>Chicago, 60637 Illinois USA </aff>
      <aff id="Aff86"><label>86</label><institution-wrap><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution>Department of Genetics, </institution><institution>Evolution and Environment, University College London, </institution></institution-wrap>London, WC1E 6BT UK </aff>
      <aff id="Aff87"><label>87</label><institution-wrap><institution-id institution-id-type="GRID">grid.8591.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 2322 4988</institution-id><institution>Department of Genetic Medicine and Development, </institution><institution>University of Geneva Medical School, </institution></institution-wrap>1211 Geneva, Switzerland </aff>
      <aff id="Aff88"><label>88</label><institution-wrap><institution-id institution-id-type="GRID">grid.8591.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 2322 4988</institution-id><institution>Institute for Genetics and Genomics in Geneva, University of Geneva, </institution></institution-wrap>1211 Geneva, Switzerland </aff>
      <aff id="Aff89"><label>89</label><institution-wrap><institution-id institution-id-type="GRID">grid.419765.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 2223 3006</institution-id><institution>Swiss Institute of Bioinformatics, </institution></institution-wrap>1211 Geneva, Switzerland </aff>
      <aff id="Aff90"><label>90</label><institution-wrap><institution-id institution-id-type="GRID">grid.411024.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2175 4264</institution-id><institution>Institute for Genome Sciences, University of Maryland School of Medicine, </institution></institution-wrap>Baltimore, 21201 Maryland USA </aff>
      <aff id="Aff91"><label>91</label><institution-wrap><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution-id institution-id-type="ISNI">0000000086837370</institution-id><institution>Department of Computational Medicine and Bioinfomatics, </institution><institution>University of Michigan, </institution></institution-wrap>Ann Arbor, 48109 Michigan USA </aff>
      <aff id="Aff92"><label>92</label><institution-wrap><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution-id institution-id-type="ISNI">0000000086837370</institution-id><institution>Department of Human Genetics, </institution><institution>University of Michigan Medical School, </institution></institution-wrap>Ann Arbor, 48109 Michigan USA </aff>
      <aff id="Aff93"><label>93</label><institution-wrap><institution-id institution-id-type="GRID">grid.21925.3d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9000</institution-id><institution>Department of Pediatrics, </institution><institution>University of Pittsburgh, </institution></institution-wrap>Pittsburgh, 15224 Pennsylvania USA </aff>
      <aff id="Aff94"><label>94</label><institution-wrap><institution-id institution-id-type="GRID">grid.267308.8</institution-id><institution-id institution-id-type="ISNI">0000 0000 9206 2401</institution-id><institution>The University of Texas Health Science Center at Houston, </institution></institution-wrap>Houston, 77030 Texas USA </aff>
      <aff id="Aff95"><label>95</label><institution-wrap><institution-id institution-id-type="GRID">grid.152326.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2264 7217</institution-id><institution>Vanderbilt University School of Medicine, </institution></institution-wrap>Nashville, 37232 Tennessee USA </aff>
      <aff id="Aff96"><label>96</label><institution-wrap><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution-id institution-id-type="ISNI">0000000086837370</institution-id><institution>University of Michigan Sequencing Core, University of Michigan, </institution></institution-wrap>Ann Arbor, 48109 Michigan USA </aff>
      <aff id="Aff97"><label>97</label><institution-wrap><institution-id institution-id-type="GRID">grid.428485.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 1789 9390</institution-id><institution>Istituto di Ricerca Genetica e Biomedica, CNR, </institution></institution-wrap>Monserrato, 09042 Cagliari Italy </aff>
      <aff id="Aff98"><label>98</label><institution-wrap><institution-id institution-id-type="GRID">grid.11450.31</institution-id><institution-id institution-id-type="ISNI">0000 0001 2097 9138</institution-id><institution>Dipartimento di Scienze Biomediche, </institution><institution>Università delgi Studi di Sassari, </institution></institution-wrap>Sassari, 07100 Italy </aff>
      <aff id="Aff99"><label>99</label><institution-wrap><institution-id institution-id-type="GRID">grid.267313.2</institution-id><institution-id institution-id-type="ISNI">0000 0000 9482 7121</institution-id><institution>University of Texas Southwestern Medical Center, </institution></institution-wrap>5323 Harry Hines Blvd, Dallas, 75390 Texas USA </aff>
      <aff id="Aff100"><label>100</label><institution-wrap><institution-id institution-id-type="GRID">grid.14848.31</institution-id><institution-id institution-id-type="ISNI">0000 0001 2292 3357</institution-id><institution>Department of Pediatrics, </institution><institution>University of Montreal, Ste. Justine Hospital Research Centre, </institution></institution-wrap>Montreal, H3T 1C5 Quebec Canada </aff>
      <aff id="Aff101"><label>101</label><institution-wrap><institution-id institution-id-type="GRID">grid.34477.33</institution-id><institution-id institution-id-type="ISNI">0000000122986657</institution-id><institution>Department of Genetics, Department of Biostatistics, Department of Computer Science, </institution><institution>University of Chapel Hill, </institution></institution-wrap>North Carolina, 27599 USA </aff>
      <aff id="Aff102"><label>102</label><institution-wrap><institution-id institution-id-type="GRID">grid.266859.6</institution-id><institution-id institution-id-type="ISNI">0000 0000 8598 2218</institution-id><institution>Department of Bioinformatics and Genomics, </institution><institution>College of Computing and Informatics, University of North Carolina at Charlotte, 9201 University City Boulevard, </institution></institution-wrap>Charlotte, 28223 North Carolina USA </aff>
      <aff id="Aff103"><label>103</label><institution-wrap><institution-id institution-id-type="GRID">grid.7692.a</institution-id><institution-id institution-id-type="ISNI">0000000090126352</institution-id><institution>Department of Medical Genetics, </institution><institution>Center for Molecular Medicine, University Medical Center Utrecht, </institution></institution-wrap>Utrecht, The Netherlands </aff>
      <aff id="Aff104"><label>104</label><institution-wrap><institution-id institution-id-type="GRID">grid.267044.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 0398 9176</institution-id><institution>Department of Biology, </institution><institution>University of Puerto Rico at Mayagüez, </institution></institution-wrap>Mayagüez, 00680 Puerto Rico USA </aff>
      <aff id="Aff105"><label>105</label><institution-wrap><institution-id institution-id-type="GRID">grid.223827.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2193 0096</institution-id><institution>Eccles Institute of Human Genetics, University of Utah School of Medicine, </institution></institution-wrap>Salt Lake City, 84112 Utah USA </aff>
      <aff id="Aff106"><label>106</label><institution-wrap><institution-id institution-id-type="GRID">grid.430387.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8796</institution-id><institution>Department of Genetics, </institution><institution>Rutgers University, Piscataway, </institution></institution-wrap>New Jersey, 08854 USA </aff>
      <aff id="Aff107"><label>107</label><institution-wrap><institution-id institution-id-type="GRID">grid.34477.33</institution-id><institution-id institution-id-type="ISNI">0000000122986657</institution-id><institution>Department of Medicine, Division of Medical Genetics, </institution><institution>University of Washington, </institution></institution-wrap>Seattle, 98195 Washington USA </aff>
      <aff id="Aff108"><label>108</label><institution-wrap><institution-id institution-id-type="GRID">grid.34477.33</institution-id><institution-id institution-id-type="ISNI">0000000122986657</institution-id><institution>Department of Biostatistics, </institution><institution>University of Washington, </institution></institution-wrap>Seattle, 98195 Washington USA </aff>
      <aff id="Aff109"><label>109</label><institution-wrap><institution-id institution-id-type="GRID">grid.5386.8</institution-id><institution-id institution-id-type="ISNI">000000041936877X</institution-id><institution>Department of Physiology and Biophysics, </institution><institution>Weill Cornell Medical College, New York, New York 10065, USA, </institution></institution-wrap>, </aff>
      <aff id="Aff110"><label>110</label><institution-wrap><institution-id institution-id-type="GRID">grid.10417.33</institution-id><institution-id institution-id-type="ISNI">0000 0004 0444 9382</institution-id><institution>Department of Human Genetics, </institution><institution>Radboud Institute for Molecular Life Sciences and Donders Centre for Neuroscience, Radboud University Medical Center, </institution></institution-wrap>Geert Grooteplein 10, GA Nijmegen, 6525 The Netherlands </aff>
      <aff id="Aff111"><label>111</label><institution-wrap><institution-id institution-id-type="GRID">grid.5590.9</institution-id><institution-id institution-id-type="ISNI">0000000122931605</institution-id><institution>Department of Molecular Developmental Biology, </institution><institution>Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University, </institution></institution-wrap>Nijmegen, 6500 HB The Netherlands </aff>
      <aff id="Aff112"><label>112</label><institution-wrap><institution-id institution-id-type="GRID">grid.419869.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1758 2860</institution-id><institution>Institute of Genetics and Biophysics, National Research Council (CNR), </institution></institution-wrap>Naples, 80125 Italy </aff>
      <aff id="Aff113"><label>113</label><institution-wrap><institution-id institution-id-type="GRID">grid.47100.32</institution-id><institution-id institution-id-type="ISNI">0000000419368710</institution-id><institution>Program in Computational Biology and Bioinformatics, Yale University, </institution></institution-wrap>New Haven, 06520 Connecticut USA </aff>
      <aff id="Aff114"><label>114</label><institution-wrap><institution-id institution-id-type="GRID">grid.47100.32</institution-id><institution-id institution-id-type="ISNI">0000000419368710</institution-id><institution>Department of Computer Science, </institution><institution>Yale University, </institution></institution-wrap>New Haven, 06520 Connecticut USA </aff>
      <aff id="Aff115"><label>115</label><institution-wrap><institution-id institution-id-type="GRID">grid.47100.32</institution-id><institution-id institution-id-type="ISNI">0000000419368710</institution-id><institution>Department of Molecular Biophysics and Biochemistry, </institution><institution>Yale University, </institution></institution-wrap>New Haven, 06520 Connecticut USA </aff>
      <aff id="Aff116"><label>116</label><institution-wrap><institution-id institution-id-type="GRID">grid.66875.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 0459 167X</institution-id><institution>Department of Health Sciences Research, </institution><institution>Mayo Clinic, </institution></institution-wrap>Rochester, 55905 Minnesota USA </aff>
      <aff id="Aff117"><label>117</label><institution-wrap><institution-id institution-id-type="GRID">grid.47100.32</institution-id><institution-id institution-id-type="ISNI">0000000419368710</institution-id><institution>Department of Chemistry, </institution><institution>Yale University, </institution></institution-wrap>New Haven, 06520 Connecticut USA </aff>
      <aff id="Aff118"><label>118</label><institution-wrap><institution-id institution-id-type="GRID">grid.10419.3d</institution-id><institution-id institution-id-type="ISNI">0000000089452978</institution-id><institution>Department of Medical Statistics and Bioinformatics, </institution><institution>Molecular Epidemiology Section, Leiden University Medical Center, </institution></institution-wrap>2333 ZA The Netherlands </aff>
      <aff id="Aff119"><label>119</label><institution-wrap><institution-id institution-id-type="GRID">grid.266100.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2107 4242</institution-id><institution>Department of Computer Science, </institution><institution>University of California, </institution></institution-wrap>San Diego, La Jolla, 92093, California USA </aff>
      <aff id="Aff120"><label>120</label><institution-wrap><institution-id institution-id-type="GRID">grid.266100.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2107 4242</institution-id><institution>Beyster Center for Genomics of Psychiatric Diseases, University of California, </institution></institution-wrap>San Diego, La Jolla, 92093 California USA </aff>
      <aff id="Aff121"><label>121</label><institution-wrap><institution-id institution-id-type="GRID">grid.240145.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2291 4776</institution-id><institution>Department of Bioinformatics and Computational Biology, </institution><institution>The University of Texas MD Anderson Cancer Center, </institution></institution-wrap>Houston, 77230 Texas USA </aff>
      <aff id="Aff122"><label>122</label>Bina Technologies, Roche Sequencing, Redwood City, 94065 California USA </aff>
      <aff id="Aff123"><label>123</label><institution-wrap><institution-id institution-id-type="GRID">grid.32224.35</institution-id><institution-id institution-id-type="ISNI">0000 0004 0386 9924</institution-id><institution>Department of Surgery, </institution><institution>Massachusetts General Hospital, </institution></institution-wrap>Boston, 02114 Massachusetts USA </aff>
      <aff id="Aff124"><label>124</label><institution-wrap><institution-id institution-id-type="GRID">grid.5170.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2181 8870</institution-id><institution>Department of Systems Biology, </institution><institution>Center for Biological Sequence Analysis, Technical University of Denmark, </institution></institution-wrap>Kemitorvet Building 208, Lyngby, 2800 Denmark </aff>
      <aff id="Aff125"><label>125</label><institution-wrap><institution-id institution-id-type="GRID">grid.241963.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 2152 1081</institution-id><institution>Sackler Institute for Comparative Genomics, American Museum of Natural History, </institution></institution-wrap>New York, 10024 New York USA </aff>
      <aff id="Aff126"><label>126</label><institution-wrap><institution-id institution-id-type="GRID">grid.241963.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 2152 1081</institution-id><institution>Department of Invertebrate Zoology, </institution><institution>American Museum of Natural History, </institution></institution-wrap>New York, 10024 New York USA </aff>
      <aff id="Aff127"><label>127</label><institution-wrap><institution-id institution-id-type="GRID">grid.215654.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2151 2636</institution-id><institution>School of Life Sciences, Arizona State University, </institution></institution-wrap>Tempe, 85287-4701 Arizona USA </aff>
      <aff id="Aff128"><label>128</label><institution-wrap><institution-id institution-id-type="GRID">grid.168010.e</institution-id><institution-id institution-id-type="ISNI">0000000419368956</institution-id><institution>Program in Biomedical Informatics, Stanford University, </institution></institution-wrap>Stanford, 94305 California USA </aff>
      <aff id="Aff129"><label>129</label><institution-wrap><institution-id institution-id-type="GRID">grid.1003.2</institution-id><institution-id institution-id-type="ISNI">0000 0000 9320 7537</institution-id><institution>Institute for Molecular Bioscience, University of Queensland, </institution></institution-wrap>St Lucia, QLD 4072 Australia </aff>
      <aff id="Aff130"><label>130</label><institution-wrap><institution-id institution-id-type="GRID">grid.438526.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 0694 4940</institution-id><institution>Virginia Bioinformatics Institute, </institution></institution-wrap>1015 Life Sciences Drive, Blacksburg, 24061 Virginia USA </aff>
      <aff id="Aff131"><label>131</label><institution-wrap><institution-id institution-id-type="GRID">grid.21107.35</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9311</institution-id><institution>Division of Allergy and Clinical Immunology, </institution><institution>School of Medicine, Johns Hopkins University, </institution></institution-wrap>Baltimore, 21205 Maryland USA </aff>
      <aff id="Aff132"><label>132</label><institution-wrap><institution-id institution-id-type="GRID">grid.36425.36</institution-id><institution-id institution-id-type="ISNI">0000 0001 2216 9681</institution-id><institution>Department of Ecology and Evolution, </institution><institution>Stony Brook University, Stony Brook, </institution></institution-wrap>11794 New York USA </aff>
      <aff id="Aff133"><label>133</label><institution-wrap><institution-id institution-id-type="GRID">grid.4991.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8948</institution-id><institution>Centre for Health, Law and Emerging Technologies, University of Oxford, </institution></institution-wrap>Oxford, OX3 7LF UK </aff>
      <aff id="Aff134"><label>134</label>Genetic Alliance, London, N1 3QP UK </aff>
      <aff id="Aff135"><label>135</label><institution-wrap><institution-id institution-id-type="GRID">grid.4991.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8948</institution-id><institution>Nuffield Department of Population Health, </institution><institution>The Ethox Center, University of Oxford, Old Road Campus, </institution></institution-wrap>OX3 7LF UK </aff>
      <aff id="Aff136"><label>136</label><institution-wrap><institution-id institution-id-type="GRID">grid.21107.35</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9311</institution-id><institution>Johns Hopkins University School of Medicine, </institution></institution-wrap>Baltimore, 21205 Maryland USA </aff>
      <aff id="Aff137"><label>137</label><institution-wrap><institution-id institution-id-type="GRID">grid.14003.36</institution-id><institution-id institution-id-type="ISNI">0000 0001 2167 3675</institution-id><institution>Department of Medical History and Bioethics, </institution><institution>Morgridge Institute for Research, University of Wisconsin-Madison, </institution></institution-wrap>Madison, 53706 Wisconsin USA </aff>
      <aff id="Aff138"><label>138</label><institution-wrap><institution-id institution-id-type="GRID">grid.14003.36</institution-id><institution-id institution-id-type="ISNI">0000 0001 2167 3675</institution-id><institution>University of Wisconsin Law School, </institution></institution-wrap>Madison, 53706 Wisconsin USA </aff>
      <aff id="Aff139"><label>139</label><institution-wrap><institution-id institution-id-type="GRID">grid.280128.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2233 9230</institution-id><institution>US National Institutes of Health, Center for Research on Genomics and Global Health, National Human Genome Research Institute, </institution></institution-wrap>12 South Drive, Bethesda, 20892 Maryland USA </aff>
      <aff id="Aff140"><label>140</label><institution-wrap><institution-id institution-id-type="GRID">grid.26009.3d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7961</institution-id><institution>Department of African &amp; African American Studies, </institution><institution>Duke University, </institution></institution-wrap>Durham, North, 27708 Carolina USA </aff>
      <aff id="Aff141"><label>141</label><institution-wrap><institution-id institution-id-type="GRID">grid.25879.31</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8972</institution-id><institution>Department of Genetics, </institution><institution>University of Pennsylvania School of Medicine, </institution></institution-wrap>Philadelphia, 19104 Pennsylvania USA </aff>
      <aff id="Aff142"><label>142</label><institution-wrap><institution-id institution-id-type="GRID">grid.5841.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0247</institution-id><institution>Department of Psychiatry and Clinical Psychobiology &amp; Institute for Brain, </institution><institution>Cognition and Behavior (IR3C), University of Barcelona, </institution></institution-wrap>Barcelona, 08035 Spain </aff>
      <aff id="Aff143"><label>143</label><institution-wrap><institution-id institution-id-type="GRID">grid.4991.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8948</institution-id><institution>Cancer and Immunogenetics Laboratory, University of Oxford, John Radcliffe Hospital, </institution></institution-wrap>Oxford, OX3 9DS UK </aff>
      <aff id="Aff144"><label>144</label><institution-wrap><institution-id institution-id-type="GRID">grid.412881.6</institution-id><institution-id institution-id-type="ISNI">0000 0000 8882 5269</institution-id><institution>Laboratory of Molecular Genetics, Institute of Biology, University of Antioquia, Medellín, </institution></institution-wrap>Colombia </aff>
      <aff id="Aff145"><label>145</label><institution-wrap><institution-id institution-id-type="GRID">grid.440601.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 1798 0578</institution-id><institution>Peking University Shenzhen Hospital, </institution></institution-wrap>Shenzhen, 518036 China </aff>
      <aff id="Aff146"><label>146</label><institution-wrap><institution-id institution-id-type="GRID">grid.12527.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 0662 3178</institution-id><institution>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, </institution></institution-wrap>Kunming, 650118 China </aff>
      <aff id="Aff147"><label>147</label><institution-wrap><institution-id institution-id-type="GRID">grid.428472.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 1794 2467</institution-id><institution>Instituto de Biologia Molecular y Celular del Cancer, Centro de Investigacion del Cancer/IBMCC (CSIC-USAL), Institute of Biomedical Research of Salamanca (IBSAL) &amp; National DNA Bank Carlos III, University of Salamanca, </institution></institution-wrap>Salamanca, 37007 Spain </aff>
      <aff id="Aff148"><label>148</label><institution-wrap><institution-id institution-id-type="GRID">grid.262009.f</institution-id><institution>Ponce Research Institute, Ponce Health Sciences University, </institution></institution-wrap>Ponce, 00716 Puerto Rico </aff>
      <aff id="Aff149"><label>149</label>Chronic Disease Research Centre, Tropical Medicine Research Institute, Cave Hill Campus, The University of the West Indies, , </aff>
      <aff id="Aff150"><label>150</label>Faculty of Medical Sciences, Cave Hill Campus, The University of the West Indies, , </aff>
      <aff id="Aff151"><label>151</label>Tropical Metabolism Research Unit, Tropical Medicine Research Institute, Mona Campus, The University of the West Indies, , </aff>
      <aff id="Aff152"><label>152</label><institution-wrap><institution-id institution-id-type="GRID">grid.414142.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 0600 7174</institution-id><institution>International Centre for Diarrhoeal Disease Research, </institution></institution-wrap>Dhaka, Bangladesh </aff>
      <aff id="Aff153"><label>153</label>Xishuangbanna Health School, Xishuangbanna, 666100 China </aff>
      <aff id="Aff154"><label>154</label><institution-wrap><institution-id institution-id-type="GRID">grid.508091.5</institution-id><institution>Irrua Specialist Teaching Hospital, </institution></institution-wrap>Edo State, Nigeria </aff>
      <aff id="Aff155"><label>155</label><institution-wrap><institution-id institution-id-type="GRID">grid.442553.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 0622 6369</institution-id><institution>Redeemers University, </institution></institution-wrap>Ogun State, Nigeria </aff>
      <aff id="Aff156"><label>156</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Harvard T. H. Chan School of Public Health, </institution></institution-wrap>Boston, 02115 Massachusetts USA </aff>
      <aff id="Aff157"><label>157</label><institution-wrap><institution-id institution-id-type="GRID">grid.415063.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0606 294X</institution-id><institution>Medical Research Council Unit, The Gambia, Atlantic Boulevard, </institution></institution-wrap>Fajara, P.O. Box 273, Banjul, The Gambia </aff>
      <aff id="Aff158"><label>158</label><institution-wrap><institution-id institution-id-type="GRID">grid.7445.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2113 8111</institution-id><institution>NHLI, Imperial College London, Hammersmith Hospital, </institution></institution-wrap>London, SW7 2AZ UK </aff>
      <aff id="Aff159"><label>159</label><institution-wrap><institution-id institution-id-type="GRID">grid.412433.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 0429 6814</institution-id><institution>Centre for Tropical Medicine, Oxford University Clinical Research Unit, </institution></institution-wrap>Ho Chi Minh City, Vietnam </aff>
      <aff id="Aff160"><label>160</label><institution-wrap><institution-id institution-id-type="GRID">grid.1008.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 2179 088X</institution-id><institution>Peter Doherty Institute of Infection and Immunity, The University of Melbourne, </institution></institution-wrap>792 Elizabeth Street, Melbourne, 3000 VIC Australia </aff>
      <aff id="Aff161"><label>161</label><institution-wrap><institution-id institution-id-type="GRID">grid.463455.5</institution-id><institution>Kenema Government Hospital, Ministry of Health and Sanitation, </institution></institution-wrap>Kenema, Sierra Leone </aff>
      <aff id="Aff162"><label>162</label><institution-wrap><institution-id institution-id-type="GRID">grid.265219.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 2217 8588</institution-id><institution>Tulane University Health Sciences Center, </institution></institution-wrap>New Orleans, 70112 Louisiana USA </aff>
      <aff id="Aff163"><label>163</label><institution-wrap><institution-id institution-id-type="GRID">grid.11100.31</institution-id><institution-id institution-id-type="ISNI">0000 0001 0673 9488</institution-id><institution>Laboratorios de Investigación y Desarrollo, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, </institution></institution-wrap>Peru </aff>
      <aff id="Aff164"><label>164</label><institution-wrap><institution-id institution-id-type="GRID">grid.497620.e</institution-id><institution>Center for Non-Communicable Diseases, </institution></institution-wrap>Karachi, Pakistan </aff>
      <aff id="Aff165"><label>165</label><institution-wrap><institution-id institution-id-type="GRID">grid.25879.31</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8972</institution-id><institution>Department of Epidemiology and Biostatistics, </institution><institution>Perelman School of Medicine, University of Pennsylvania, </institution></institution-wrap>Philadelphia, 19104 Pennsylvania USA </aff>
      <aff id="Aff166"><label>166</label><institution-wrap><institution-id institution-id-type="GRID">grid.280128.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2233 9230</institution-id><institution>US National Institutes of Health, National Human Genome Research Institute, </institution></institution-wrap>5635 Fishers Lane, Bethesda, 20892 Maryland USA </aff>
      <aff id="Aff167"><label>167</label><institution-wrap><institution-id institution-id-type="GRID">grid.52788.30</institution-id><institution-id institution-id-type="ISNI">0000 0004 0427 7672</institution-id><institution>Wellcome Trust, Gibbs Building, </institution></institution-wrap>215 Euston Road, London, NW1 2BE UK </aff>
      <aff id="Aff168"><label>168</label><institution-wrap><institution-id institution-id-type="GRID">grid.13402.34</institution-id><institution-id institution-id-type="ISNI">0000 0004 1759 700X</institution-id><institution>James D. Watson Institute of Genome Sciences, </institution></institution-wrap>Hangzhou, 310008 China </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>30</day>
      <month>9</month>
      <year>2015</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>30</day>
      <month>9</month>
      <year>2015</year>
    </pub-date>
    <pub-date pub-type="ppub">
      <year>2015</year>
    </pub-date>
    <volume>526</volume>
    <issue>7571</issue>
    <fpage>68</fpage>
    <lpage>74</lpage>
    <history>
      <date date-type="received">
        <day>12</day>
        <month>5</month>
        <year>2015</year>
      </date>
      <date date-type="accepted">
        <day>20</day>
        <month>8</month>
        <year>2015</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2015</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbyncsalicense">https://creativecommons.org/licenses/by-nc-sa/3.0/</ali:license_ref>
        <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported licence. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons licence, users will need to obtain permission from the licence holder to reproduce the material. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-sa/3.0/">http://creativecommons.org/licenses/by-nc-sa/3.0/</ext-link>.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <p id="Par1">The 1000 Genomes Project set out to provide a comprehensive description of common human genetic variation by applying whole-genome sequencing to a diverse set of individuals from multiple populations. Here we report completion of the project, having reconstructed the genomes of 2,504 individuals from 26 populations using a combination of low-coverage whole-genome sequencing, deep exome sequencing, and dense microarray genotyping. We characterized a broad spectrum of genetic variation, in total over 88 million variants (84.7 million single nucleotide polymorphisms (SNPs), 3.6 million short insertions/deletions (indels), and 60,000 structural variants), all phased onto high-quality haplotypes. This resource includes &gt;99% of SNP variants with a frequency of &gt;1% for a variety of ancestries. We describe the distribution of genetic variation across the global sample, and discuss the implications for common disease studies.</p>
      <sec>
        <title>Supplementary information</title>
        <p>The online version of this article (doi:10.1038/nature15393) contains supplementary material, which is available to authorized users.</p>
      </sec>
    </abstract>
    <abstract id="Abs2" abstract-type="web-summary">
      <p id="Par2">Results for the final phase of the 1000 Genomes Project are presented including whole-genome sequencing, targeted exome sequencing, and genotyping on high-density SNP arrays for 2,504 individuals across 26 populations, providing a global reference data set to support biomedical genetics.</p>
      <sec>
        <title>Supplementary information</title>
        <p>The online version of this article (doi:10.1038/nature15393) contains supplementary material, which is available to authorized users.</p>
      </sec>
    </abstract>
    <abstract id="Abs3" abstract-type="LongSummary">
      <title>Human genetic variation in more than 2,500 individuals</title>
      <p id="Par3">The 1000 Genomes Project has sought to comprehensively catalogue human genetic variation across populations, providing a valuable public genomic resource. The data obtained so far have found applications ranging from association studies and fine mapping studies to the filtering of likely neutral variants in rare-disease cohorts. The authors now report on the final phase of the project, phase 3, which covers previously uncharacterized areas of human genetic diversity in terms of the populations sampled and categories of characterized variation. The sample now includes more than 2,500 individuals from 26 global populations, with low coverage whole-genome and deep exome sequencing, as well as dense microarray genotyping. They find that while most common variants are shared across populations, rarer variants are often restricted to closely related populations. The authors also demonstrate the use of the phase 3 dataset as a reference panel for imputation to improve the resolution in genetic association studies.</p>
      <sec>
        <title>Supplementary information</title>
        <p>The online version of this article (doi:10.1038/nature15393) contains supplementary material, which is available to authorized users.</p>
      </sec>
    </abstract>
    <kwd-group kwd-group-type="npg-subject">
      <title>Subject terms</title>
      <kwd>Genomics</kwd>
      <kwd>Genetic variation</kwd>
    </kwd-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© Springer Nature Limited 2015</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Main</title>
    <p id="Par4">The 1000 Genomes Project has already elucidated the properties and distribution of common and rare variation, provided insights into the processes that shape genetic diversity, and advanced understanding of disease biology<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>. This resource provides a benchmark for surveys of human genetic variation and constitutes a key component for human genetic studies, by enabling array design<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR4">4</xref></sup>, genotype imputation<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>, cataloguing of variants in regions of interest, and filtering of likely neutral variants<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR7">7</xref></sup>.</p>
    <p id="Par5">In this final phase, individuals were sampled from 26 populations in Africa (AFR), East Asia (EAS), Europe (EUR), South Asia (SAS), and the Americas (AMR) (<xref rid="Fig1" ref-type="fig">Fig. 1a</xref>; see <xref rid="MOESM86" ref-type="media">Supplementary Table 1</xref> for population descriptions and abbreviations). All individuals were sequenced using both whole-genome sequencing (mean depth = 7.4×) and targeted exome sequencing (mean depth = 65.7×). In addition, individuals and available first-degree relatives (generally, adult offspring) were genotyped using high-density SNP microarrays. This provided a cost-effective means to discover genetic variants and estimate individual genotypes and haplotypes<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>.<fig id="Fig1"><label>Figure 1</label><caption><title>Population sampling.</title><p><bold>a,</bold> Polymorphic variants within sampled populations. The area of each pie is proportional to the number of polymorphisms within a population. Pies are divided into four slices, representing variants private to a population (darker colour unique to population), private to a continental area (lighter colour shared across continental group), shared across continental areas (light grey), and shared across all continents (dark grey). Dashed lines indicate populations sampled outside of their ancestral continental region. <bold>b,</bold> The number of variant sites per genome. <bold>c,</bold> The average number of singletons per genome.</p><p><xref rid="MOESM82" ref-type="media">PowerPoint slide</xref></p></caption><graphic xlink:href="41586_2015_Article_BFnature15393_Fig1_HTML" id="d32e8424"/></fig></p>
  </sec>
  <sec id="Sec2">
    <title>Data set overview</title>
    <p id="Par6">In contrast to earlier phases of the project, we expanded analysis beyond bi-allelic events to include multi-allelic SNPs, indels, and a diverse set of structural variants (SVs). An overview of the sample collection, data generation, data processing, and analysis is given in <xref rid="Fig5" ref-type="fig">Extended Data Fig. 1</xref>. Variant discovery used an ensemble of 24 sequence analysis tools (<xref rid="MOESM86" ref-type="media">Supplementary Table 2</xref>), and machine-learning classifiers to separate high-quality variants from potential false positives, balancing sensitivity and specificity. Construction of haplotypes started with estimation of long-range phased haplotypes using array genotypes for project participants and, where available, their first degree relatives; continued with the addition of high confidence bi-allelic variants that were analysed jointly to improve these haplotypes; and concluded with the placement of multi-allelic and structural variants onto the haplotype scaffold one at a time (<xref rid="Sec3" ref-type="sec">Box 1</xref>). Overall, we discovered, genotyped, and phased 88 million variant sites (<xref rid="MOESM86" ref-type="media">Supplementary Table 3</xref>). The project has now contributed or validated 80 million of the 100 million variants in the public dbSNP catalogue (version 141 includes 40 million SNPs and indels newly contributed by this analysis). These novel variants especially enhance our catalogue of genetic variation within South Asian (which account for 24% of novel variants) and African populations (28% of novel variants).</p>
    <p id="Par7">To control the false discovery rate (FDR) of SNPs and indels at &lt;5%, a variant quality score threshold was defined using high depth (&gt;30×) PCR-free sequence data generated for one individual per population. For structural variants, additional orthogonal methods were used for confirmation, including microarrays and long-read sequencing, resulting in FDR &lt; 5% for deletions, duplications, multi-allelic copy-number variants, Alu and L1 insertions, and &lt;20% for inversions, SVA (SINE/VNTR/Alu) composite retrotransposon insertions and NUMTs<sup><xref ref-type="bibr" rid="CR8">8</xref></sup> (nuclear mitochondrial DNA variants). To evaluate variant discovery power and genotyping accuracy, we also generated deep Complete Genomics data (mean depth = 47×) for 427 individuals (129 mother–father–child trios, 12 parent–child duos, and 16 unrelateds). We estimate the power to detect SNPs and indels to be &gt;95% and &gt;80%, respectively, for variants with sample frequency of at least 0.5%, rising to &gt;99% and &gt;85% for frequencies &gt;1% (<xref rid="Fig6" ref-type="fig">Extended Data Fig. 2</xref>). At lower frequencies, comparison with &gt;60,000 European haplotypes from the Haplotype Reference Consortium<sup><xref ref-type="bibr" rid="CR9">9</xref></sup> suggests 75% power to detect SNPs with frequency of 0.1%. Furthermore, we estimate heterozygous genotype accuracy at 99.4% for SNPs and 99.0% for indels (<xref rid="MOESM86" ref-type="media">Supplementary Table 4</xref>), a threefold reduction in error rates compared to our previous release<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>, resulting from the larger sample size, improvements in sequence data accuracy, and genotype calling and phasing algorithms.</p>
    <sec id="Sec3">
      <boxed-text>
        <label>Box 1: Building a haplotype scaffold</label>
        <p id="Par8">To construct high quality haplotypes that integrate multiple variant types, we adopted a staged approach<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. (1) A high-quality ‘haplotype scaffold’ was constructed using statistical methods applied to SNP microarray genotypes (black circles) and, where available, genotypes for first degree relatives (available for ∼52% of samples; <xref rid="MOESM86" ref-type="media">Supplementary Table 11</xref>)<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. (2a) Variant sites were identified using a combination of bioinformatic tools and pipelines to define a set of high-confidence bi-allelic variants, including both SNPs and indels (white triangles), which were jointly imputed onto the haplotype scaffold. (2b) Multi-allelic SNPs, indels, and complex variants (represented by yellow shapes, or variation in copy number) were placed onto the haplotype scaffold one at a time, exploiting the local linkage disequilibrium information but leaving haplotypes for other variants undisturbed<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. (3) The biallelic and multi-allelic haplotypes were merged into a single haplotype representation. This multi-stage approach allows the long-range structure of the haplotype scaffold to be maintained while including more complex types of variation. Comparison to haplotypes constructed from fosmids suggests the average distance between phasing errors is ∼1,062 kb, with typical phasing errors stretching ∼37 kb (<xref rid="MOESM86" ref-type="media">Supplementary Table 12</xref>).<graphic position="anchor" xlink:href="41586_2015_Article_BFnature15393_Figa_HTML" id="d32e8488"/></p>
      </boxed-text>
    </sec>
  </sec>
  <sec id="Sec4">
    <title>A typical genome</title>
    <p id="Par9">We find that a typical genome differs from the reference human genome at 4.1 million to 5.0 million sites (<xref rid="Fig1" ref-type="fig">Fig. 1b</xref> and <xref rid="Tab1" ref-type="table">Table 1</xref>). Although &gt;99.9% of variants consist of SNPs and short indels, structural variants affect more bases: the typical genome contains an estimated 2,100 to 2,500 structural variants (∼1,000 large deletions, ∼160 copy-number variants, ∼915 Alu insertions, ∼128 L1 insertions, ∼51 SVA insertions, ∼4 NUMTs, and ∼10 inversions), affecting ∼20 million bases of sequence.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Median autosomal variant sites per genome</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="center" colspan="2">AFR</th><th align="center" colspan="2">AMR</th><th align="center" colspan="2">EAS</th><th align="center" colspan="2">EUR</th><th align="center" colspan="2">SAS</th></tr><tr><th align="left">Samples</th><th align="center" colspan="2">661</th><th align="center" colspan="2">347</th><th align="center" colspan="2">504</th><th align="center" colspan="2">503</th><th align="center" colspan="2">489</th></tr><tr><th align="left">Mean coverage</th><th align="center" colspan="2">8.2</th><th align="center" colspan="2">7.6</th><th align="center" colspan="2">7.7</th><th align="center" colspan="2">7.4</th><th align="center" colspan="2">8.0</th></tr><tr><th align="left"/><th align="center">Var. sites</th><th align="center">Singletons</th><th align="center">Var. sites</th><th align="center">Singletons</th><th align="center">Var. sites</th><th align="center">Singletons</th><th align="center">Var. sites</th><th align="center">Singletons</th><th align="center">Var. sites</th><th align="center">Singletons</th></tr></thead><tbody><tr><td align="left">SNPs</td><td align="center">4.31M</td><td align="center">14.5k</td><td align="center">3.64M</td><td align="center">12.0k</td><td align="center">3.55M</td><td align="center">14.8k</td><td align="center">3.53M</td><td align="center">11.4k</td><td align="center">3.60M</td><td align="center">14.4k</td></tr><tr><td align="left">Indels</td><td align="center">625k</td><td align="center">-</td><td align="center">557k</td><td align="center">-</td><td align="center">546k</td><td align="center">-</td><td align="center">546k</td><td align="center">-</td><td align="center">556k</td><td align="center">-</td></tr><tr><td align="left">Large deletions</td><td align="center">1.1k</td><td align="center">5</td><td align="center">949</td><td align="center">5</td><td align="center">940</td><td align="center">7</td><td align="center">939</td><td align="center">5</td><td align="center">947</td><td align="center">5</td></tr><tr><td align="left">CNVs</td><td align="center">170</td><td align="center">1</td><td align="center">153</td><td align="center">1</td><td align="center">158</td><td align="center">1</td><td align="center">157</td><td align="center">1</td><td align="center">165</td><td align="center">1</td></tr><tr><td align="left">MEI (Alu)</td><td align="center">1.03k</td><td align="center">0</td><td align="center">845</td><td align="center">0</td><td align="center">899</td><td align="center">1</td><td align="center">919</td><td align="center">0</td><td align="center">889</td><td align="center">0</td></tr><tr><td align="left">MEI (L1)</td><td align="center">138</td><td align="center">0</td><td align="center">118</td><td align="center">0</td><td align="center">130</td><td align="center">0</td><td align="center">123</td><td align="center">0</td><td align="center">123</td><td align="center">0</td></tr><tr><td align="left">MEI (SVA)</td><td align="center">52</td><td align="center">0</td><td align="center">44</td><td align="center">0</td><td align="center">56</td><td align="center">0</td><td align="center">53</td><td align="center">0</td><td align="center">44</td><td align="center">0</td></tr><tr><td align="left">MEI (MT)</td><td align="center">5</td><td align="center">0</td><td align="center">5</td><td align="center">0</td><td align="center">4</td><td align="center">0</td><td align="center">4</td><td align="center">0</td><td align="center">4</td><td align="center">0</td></tr><tr><td align="left">Inversions</td><td align="center">12</td><td align="center">0</td><td align="center">9</td><td align="center">0</td><td align="center">10</td><td align="center">0</td><td align="center">9</td><td align="center">0</td><td align="center">11</td><td align="center">0</td></tr><tr><td align="left">Nonsynon</td><td align="center">12.2k</td><td align="center">139</td><td align="center">10.4k</td><td align="center">121</td><td align="center">10.2k</td><td align="center">144</td><td align="center">10.2k</td><td align="center">116</td><td align="center">10.3k</td><td align="center">144</td></tr><tr><td align="left">Synon</td><td align="center">13.8k</td><td align="center">78</td><td align="center">11.4k</td><td align="center">67</td><td align="center">11.2k</td><td align="center">79</td><td align="center">11.2k</td><td align="center">59</td><td align="center">11.4k</td><td align="center">78</td></tr><tr><td align="left">Intron</td><td align="center">2.06M</td><td align="center">7.33k</td><td align="center">1.72M</td><td align="center">6.12k</td><td align="center">1.68M</td><td align="center">7.39k</td><td align="center">1.68M</td><td align="center">5.68k</td><td align="center">1.72M</td><td align="center">7.20k</td></tr><tr><td align="left">UTR</td><td align="center">37.2k</td><td align="center">168</td><td align="center">30.8k</td><td align="center">136</td><td align="center">30.0k</td><td align="center">169</td><td align="center">30.0k</td><td align="center">129</td><td align="center">30.7k</td><td align="center">168</td></tr><tr><td align="left">Promoter</td><td align="center">102k</td><td align="center">430</td><td align="center">84.3k</td><td align="center">332</td><td align="center">81.6k</td><td align="center">425</td><td align="center">82.2k</td><td align="center">336</td><td align="center">84.0k</td><td align="center">430</td></tr><tr><td align="left">Insulator</td><td align="center">70.9k</td><td align="center">248</td><td align="center">59.0k</td><td align="center">199</td><td align="center">57.7k</td><td align="center">252</td><td align="center">57.7k</td><td align="center">189</td><td align="center">59.1k</td><td align="center">243</td></tr><tr><td align="left">Enhancer</td><td align="center">354k</td><td align="center">1.32k</td><td align="center">295k</td><td align="center">1.05k</td><td align="center">289k</td><td align="center">1.34k</td><td align="center">288k</td><td align="center">1.02k</td><td align="center">295k</td><td align="center">1.31k</td></tr><tr><td align="left">TFBSs</td><td align="center">927</td><td align="center">4</td><td align="center">759</td><td align="center">3</td><td align="center">748</td><td align="center">4</td><td align="center">749</td><td align="center">3</td><td align="center">765</td><td align="center">3</td></tr><tr><td align="left">Filtered LoF</td><td align="center">182</td><td align="center">4</td><td align="center">152</td><td align="center">3</td><td align="center">153</td><td align="center">4</td><td align="center">149</td><td align="center">3</td><td align="center">151</td><td align="center">3</td></tr><tr><td align="left">HGMD-DM</td><td align="center">20</td><td align="center">0</td><td align="center">18</td><td align="center">0</td><td align="center">16</td><td align="center">1</td><td align="center">18</td><td align="center">2</td><td align="center">16</td><td align="center">0</td></tr><tr><td align="left">GWAS</td><td align="center">2.00k</td><td align="center">0</td><td align="center">2.07k</td><td align="center">0</td><td align="center">1.99k</td><td align="center">0</td><td align="center">2.08k</td><td align="center">0</td><td align="center">2.06k</td><td align="center">0</td></tr><tr><td align="left">ClinVar</td><td align="center">28</td><td align="center">0</td><td align="center">30</td><td align="center">1</td><td align="center">24</td><td align="center">0</td><td align="center">29</td><td align="center">1</td><td align="center">27</td><td align="center">1</td></tr></tbody></table><table-wrap-foot><p>See <xref rid="MOESM86" ref-type="media">Supplementary Table 1</xref> for continental population groupings. CNVs, copy-number variants; HGMD-DM, Human Gene Mutation Database disease mutations; k, thousand; LoF, loss-of-function; M, million; MEI, mobile element insertions.</p></table-wrap-foot></table-wrap></p>
    <p id="Par10">The total number of observed non-reference sites differs greatly among populations (<xref rid="Fig1" ref-type="fig">Fig. 1b</xref>). Individuals from African ancestry populations harbour the greatest numbers of variant sites, as predicted by the out-of-Africa model of human origins. Individuals from recently admixed populations show great variability in the number of variants, roughly proportional to the degree of recent African ancestry in their genomes.</p>
    <p id="Par11">The majority of variants in the data set are rare: ∼64 million autosomal variants have a frequency &lt;0.5%, ∼12 million have a frequency between 0.5% and 5%, and only ∼8 million have a frequency &gt;5% (<xref rid="Fig7" ref-type="fig">Extended Data Fig. 3a</xref>). Nevertheless, the majority of variants observed in a single genome are common: just 40,000 to 200,000 of the variants in a typical genome (1–4%) have a frequency &lt;0.5% (<xref rid="Fig1" ref-type="fig">Fig. 1c</xref> and <xref rid="Fig7" ref-type="fig">Extended Data Fig. 3b</xref>). As such, we estimate that improved rare variant discovery by deep sequencing our entire sample would at least double the total number of variants in our sample but increase the number of variants in a typical genome by only ∼20,000 to 60,000.</p>
  </sec>
  <sec id="Sec5">
    <title>Putatively functional variation</title>
    <p id="Par12">When we restricted analyses to the variants most likely to affect gene function, we found a typical genome contained 149–182 sites with protein truncating variants, 10,000 to 12,000 sites with peptide-sequence-altering variants, and 459,000 to 565,000 variant sites overlapping known regulatory regions (untranslated regions (UTRs), promoters, insulators, enhancers, and transcription factor binding sites). African genomes were consistently at the high end of these ranges. The number of alleles associated with a disease or phenotype in each genome did not follow this pattern of increased diversity in Africa (<xref rid="Fig8" ref-type="fig">Extended Data Fig. 4</xref>): we observed ∼2,000 variants per genome associated with complex traits through genome-wide association studies (GWAS) and 24–30 variants per genome implicated in rare disease through ClinVar; with European ancestry genomes at the high-end of these counts. The magnitude of this difference is unlikely to be explained by demography<sup><xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR11">11</xref></sup>, but instead reflects the ethnic bias of current genetic studies. We expect that improved characterization of the clinical and phenotypic consequences of non-European alleles will enable better interpretation of genomes from all individuals and populations.</p>
  </sec>
  <sec id="Sec6">
    <title>Sharing of genetic variants among populations</title>
    <p id="Par13">Systematic analysis of the patterns in which genetic variants are shared among individuals and populations provides detailed accounts of population history. Although most common variants are shared across the world, rarer variants are typically restricted to closely related populations (<xref rid="Fig1" ref-type="fig">Fig. 1a</xref>); 86% of variants were restricted to a single continental group. Using a maximum likelihood approach<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>, we estimated the proportion of each genome derived from several putative ‘ancestral populations’ (<xref rid="Fig2" ref-type="fig">Fig. 2a</xref> and <xref rid="Fig9" ref-type="fig">Extended Data Fig. 5</xref>). This analysis separates continental groups, highlights their internal substructure, and reveals genetic similarities between related populations. For example, east–west clines are visible in Africa and East Asia, a north–south cline is visible in Europe, and European, African, and Native-American admixture is visible in genomes sampled in the Americas.<fig id="Fig2"><label>Figure 2</label><caption><title>Population structure and demography.</title><p><bold>a,</bold> Population structure inferred using a maximum likelihood approach with 8 clusters. <bold>b,</bold> Changes to effective population sizes over time, inferred using PSMC. Lines represent the within-population median PSMC estimate, smoothed by fitting a cubic spline passing through bin midpoints.</p><p><xref rid="MOESM83" ref-type="media">PowerPoint slide</xref></p></caption><graphic xlink:href="41586_2015_Article_BFnature15393_Fig2_HTML" id="d32e9397"/></fig></p>
    <p id="Par14">To characterize more recent patterns of shared ancestry, we first focused on variants observed on just two chromosomes (sample frequency of 0.04%), the rarest shared variants within our sample, and known as <italic>f</italic><sub>2</sub> variants<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. As expected, these variants are typically geographically restricted and much more likely to be shared between individuals in the same population or continental group, or between populations with known recent admixture (<xref rid="Fig10" ref-type="fig">Extended Data Fig. 6a, b</xref>). Analysis of shared haplotype lengths around <italic>f</italic><sub>2</sub> variants suggests a median common ancestor ∼296 generations ago (7,410 to 8,892 years ago; <xref rid="Fig10" ref-type="fig">Extended Data Fig. 6c, d</xref>), although those confined within a population tend to be younger, with a shared common ancestor ∼143 generations ago (3,570 to 4,284 years ago)<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>.</p>
  </sec>
  <sec id="Sec7">
    <title>Insights about demography</title>
    <p id="Par15">Modelling the distribution of variation within and between genomes can provide insights about the history and demography of our ancestor populations<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. We used the pairwise sequentially Markovian coalescent (PSMC)<sup><xref ref-type="bibr" rid="CR14">14</xref></sup> method to characterize the effective population size (<italic>N</italic><sub><italic>e</italic></sub>) of the ancestral populations (<xref rid="Fig2" ref-type="fig">Fig. 2b</xref> and <xref rid="Fig11" ref-type="fig">Extended Data Fig. 7</xref>). Our results show a shared demographic history for all humans beyond ∼150,000 to 200,000 years ago. Further, they show that European, Asian and American populations shared strong and sustained bottlenecks, all with <italic>N</italic><sub><italic>e</italic></sub> &lt; 1,500, between 15,000 to 20,000 years ago. In contrast, the bottleneck experienced by African populations during the same time period appears less severe, with <italic>N</italic><sub><italic>e</italic></sub> &gt; 4,250. These bottlenecks were followed by extremely rapid inferred population growth in non-African populations, with notable exceptions including the PEL, MXL and FIN.</p>
    <p id="Par16">Due to the shared ancestry of all humans, only a modest number of variants show large frequency differences among populations. We observed 762,000 variants that are rare (defined as having frequency &lt;0.5%) within the global sample but much more common (&gt;5% frequency) in at least one population (<xref rid="Fig3" ref-type="fig">Fig. 3a</xref>). Several populations have relatively large numbers of these variants, and these are typically genetically or geographically distinct within their continental group (LWK in Africa, PEL in the Americas, JPT in East Asia, FIN in Europe, and GIH in South Asia; see <xref rid="MOESM86" ref-type="media">Supplementary Table 5</xref>). Drifted variants within such populations may reveal phenotypic associations that would be hard to identify in much larger global samples<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>.<fig id="Fig3"><label>Figure 3</label><caption><title>Population differentiation.</title><p><bold>a,</bold> Variants found to be rare (&lt;0.5%) within the global sample, but common (&gt;5%) within a population. <bold>b,</bold> Genes showing strong differentiation between pairs of closely related populations. The vertical axis gives the maximum obtained value of the <italic>F</italic><sub>ST</sub>-based population branch statistic (PBS), with selected genes coloured to indicate the population in which the maximum value was achieved.</p><p><xref rid="MOESM84" ref-type="media">PowerPoint slide</xref></p></caption><graphic xlink:href="41586_2015_Article_BFnature15393_Fig3_HTML" id="d32e9498"/></fig></p>
    <p id="Par17">Analysis of the small set of variants with large frequency differences between closely related populations can identify targets of recent, localized adaptation. We used the <italic>F</italic><sub>ST</sub>-based population branch statistic (PBS)<sup><xref ref-type="bibr" rid="CR16">16</xref></sup> to identify genes with strong differentiation between pairs of populations in the same continental group (<xref rid="Fig3" ref-type="fig">Fig. 3b</xref>). This approach reveals a number of previously identified selection signals (such as <italic>SLC24A5</italic> associated with skin pigmentation<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, <italic>HERC2</italic> associated with eye colour<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>, <italic>LCT</italic> associated with lactose tolerance, and the <italic>FADS</italic> cluster that may be associated with dietary fat sources<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>). Several potentially novel selection signals are also highlighted (such as <italic>TRBV9</italic>, which appears particularly differentiated in South Asia, <italic>PRICKLE4</italic>, differentiated in African and South Asian populations, and a number of genes in the immunoglobulin cluster, differentiated in East Asian populations; <xref rid="Fig12" ref-type="fig">Extended Data Fig. 8</xref>), although at least some of these signals may result from somatic rearrangements (for example, via V(D)J recombination) and differences in cell type composition among the sequenced samples. Nonetheless, the relatively small number of genes showing strong differentiation between closely related populations highlights the rarity of strong selective sweeps in recent human evolution<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>.</p>
  </sec>
  <sec id="Sec8">
    <title>Sharing of haplotypes and imputation</title>
    <p id="Par18">The sharing of haplotypes among individuals is widely used for imputation in GWAS, a primary use of 1000 Genomes data. To assess imputation based on the phase 3 data set, we used Complete Genomics data for 9 or 10 individuals from each of 6 populations (CEU, CHS, LWK, PEL, PJL, and YRI). After excluding these individuals from the reference panel, we imputed genotypes across the genome using sites on a typical one million SNP microarray. The squared correlation between imputed and experimental genotypes was &gt;95% for common variants in each population, decreasing gradually with minor allele frequency (<xref rid="Fig4" ref-type="fig">Fig. 4a</xref>). Compared to phase 1, rare variation imputation improved considerably, particularly for newly sampled populations (for example, PEL and PJL, <xref rid="Fig13" ref-type="fig">Extended Data Fig. 9a</xref>). Improvements in imputations restricted to overlapping samples suggest approximately equal contributions from greater genotype and sequence quality and from increased sample size (<xref rid="Fig4" ref-type="fig">Fig. 4a</xref>, inset). Imputation accuracy is now similar for bi-allelic SNPs, bi-allelic indels, multi-allelic SNPs, and sites where indels and SNPs overlap, but slightly reduced for multi-allelic indels, which typically map to regions of low-complexity sequence and are much harder to genotype and phase (<xref rid="Fig13" ref-type="fig">Extended Data Fig. 9b</xref>). Although imputation of rare variation remains challenging, it appears to be most accurate in African ancestry populations, where greater genetic diversity results in a larger number of haplotypes and improves the chances that a rare variant is tagged by a characteristic haplotype.<fig id="Fig4"><label>Figure 4</label><caption><title>Imputation and eQTL discovery.</title><p><bold>a,</bold> Imputation accuracy as a function of allele frequency for six populations. The insert compares imputation accuracy between phase 3 and phase 1, using all samples (solid lines) and intersecting samples (dashed lines). <bold>b,</bold> The average number of tagging variants (<italic>r</italic><sup>2</sup> &gt; 0.8) as a function of physical distance for common (top), low frequency (middle), and rare (bottom) variants. <bold>c,</bold> The proportion of top eQTL variants that are SNPs and indels, as discovered in 69 samples from each population. <bold>d,</bold> The percentage of eQTLs in TFBS, having performed discovery in the first population, and fine mapped by including an additional 69 samples from a second population (*<italic>P</italic> &lt; 0.01, **<italic>P</italic> &lt; 0.001, ***<italic>P</italic> &lt; 0.0001, McNemar’s test). The diagonal represents the percentage of eQTLs in TFBS using the original discovery sample.</p><p><xref rid="MOESM85" ref-type="media">PowerPoint slide</xref></p></caption><graphic xlink:href="41586_2015_Article_BFnature15393_Fig4_HTML" id="d32e9608"/></fig></p>
  </sec>
  <sec id="Sec9">
    <title>Resolution of genetic association studies</title>
    <p id="Par19">To evaluate the impact of our new reference panel on GWAS, we re-analysed a previous study of age-related macular degeneration (AMD) totalling 2,157 cases and 1,150 controls<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. We imputed 17.0 million genetic variants with estimated <italic>R</italic><sup>2</sup> &gt; 0.3, compared to 14.1 million variants using phase 1, and only 2.4 million SNPs using HapMap2. Compared to phase 1, the number of imputed common and intermediate frequency variants increased by 7%, whereas the number of rare variants increased by &gt;50%, and the number of indels increased by 70% (<xref rid="MOESM86" ref-type="media">Supplementary Table 6</xref>). We permuted case-control labels to estimate a genome-wide significance threshold of <italic>P</italic> &lt; ∼1.5 × 10<sup>−8</sup>, which corresponds to ∼3 million independent variants and is more stringent than the traditional threshold of 5 × 10<sup>−8</sup> (<xref rid="MOESM86" ref-type="media">Supplementary Table 7</xref>). In practice, significance thresholds must balance false positives and false negatives<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR24">24</xref></sup>. We recommend that thresholds aiming for strict control of false positives should be determined using permutations. We expect thresholds to become more stringent when larger sample sizes are sequenced, when diverse samples are studied, or when genotyping and imputation is replaced with direct sequencing. After imputation, five independent signals in four previously reported AMD loci<sup><xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR28">28</xref></sup> reached genome-wide significance (<xref rid="MOESM86" ref-type="media">Supplementary Table 8</xref>). When we examined each of these to define a set of potentially causal variants using a Bayesian Credible set approach<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>, lists of potentially functional variants were ∼4× larger than in HapMap2-based analysis and 7% larger than in analyses based on phase 1 (<xref rid="MOESM86" ref-type="media">Supplementary Table 9</xref>). In the <italic>ARMS2/HTRA1</italic> locus, the most strongly associated variant was now a structural variant (estimated imputation <italic>R</italic><sup>2</sup> = 0.89) that previously could not be imputed, consistent with some functional studies<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. Deep catalogues of potentially functional variants will help ensure that downstream functional analyses include the true candidate variants, and will aid analyses that integrate complex disease associations with functional genomic elements<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>.</p>
    <p id="Par20">The performance of imputation and GWAS studies depends on the local distribution of linkage disequilibrium (LD) between nearby variants. Controlling for sample size, the decay of LD as a function of physical distance is fastest in African populations and slowest in East Asian populations (<xref rid="Fig14" ref-type="fig">Extended Data Fig. 10</xref>). To evaluate how these differences influence the resolution of genetic association studies and, in particular, their ability to identify a narrow set of candidate functional variants, we evaluated the number of tagging variants (<italic>r</italic><sup>2</sup> &gt; 0.8) for a typical variant in each population. We find that each common variant typically has over 15–20 tagging variants in non-African populations, but only about 8 in African populations (<xref rid="Fig4" ref-type="fig">Fig. 4b</xref>). At lower frequencies, we find 3–6 tagging variants with 100 kb of variants with frequency &lt;0.5%, and differences in the number of tagging variants between continental groups are less marked.</p>
    <p id="Par21">Among variants in the GWAS catalogue (which have an average frequency of 26.6% in project haplotypes), the number of proxies averages 14.4 in African populations and 30.3–44.4 in other continental groupings (<xref rid="MOESM86" ref-type="media">Supplementary Table 10</xref>). The potential value of multi-population fine-mapping is illustrated by the observation that the number of proxies shared across all populations is only 8.2 and, furthermore, that 34.9% of GWAS catalogue variants have no proxy shared across all continental groupings.</p>
    <p id="Par22">To further assess prospects for fine-mapping genetic association signals, we performed expression quantitative trait loci (eQTL) discovery at 17,667 genes in 69 samples from each of 6 populations (CEU, CHB, GIH, JPT, LWK, and YRI)<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. We identified eQTLs for 3,285 genes at 5% FDR (average 1,265 genes per population). Overall, a typical eQTL signal comprised 67 associated variants, including an indel as one of the top associated variants 26–40% of the time (<xref rid="Fig4" ref-type="fig">Fig. 4c</xref>). Within each discovery population, 17.5–19.5% of top eQTL variants overlapped annotated transcription factor binding sites (TFBSs), consistent with the idea that a substantial fraction of eQTL polymorphisms are TFBS polymorphisms. Using a meta-analysis approach to combine pairs of populations, the proportion of top eQTL variants overlapping TFBSs increased to 19.2–21.6% (<xref rid="Fig4" ref-type="fig">Fig. 4d</xref>), consistent with improved localization. Including an African population provided the greatest reduction in the count of associated variants and the greatest increase in overlap between top variants and TFBSs.</p>
  </sec>
  <sec id="Sec10">
    <title>Discussion</title>
    <p id="Par23">Over the course of the 1000 Genomes Project there have been substantial advances in sequence data generation, archiving and analysis. Primary sequence data production improved with increased read length and depth, reduced per-base errors, and the introduction of paired-end sequencing. Sequence analysis methods improved with the development of strategies for identifying and filtering poor-quality data, for more accurate mapping of sequence reads (particularly in repetitive regions), for exchanging data between analysis tools and enabling ensemble analyses, and for capturing more diverse types of variants. Importantly, each release has examined larger numbers of individuals, aiding population-based analyses that identify and leverage shared haplotypes during genotyping. Whereas our first analyses produced high-confidence short-variant calls for 80–85% of the reference genome<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>, our newest analyses reach ∼96% of the genome using the same metrics, although our ability to accurately capture structural variation remains more limited<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. In addition, the evolution of sequencing, analysis and filtering strategies means that our results are not a simple superset of previous analysis. Although the number of characterized variants has more than doubled relative to phase 1, ∼2.3 million previously described variants are not included in the current analysis; most missing variants were rare or marked as low quality: 1.6 million had frequency &lt;0.5% and may be missing from our current read set, while the remainder were removed by our filtering processes.</p>
    <p id="Par24">These same technical advances are enabling the application of whole genome sequencing to a variety of medically important samples. Some of these studies already exceed the 1000 Genomes Project in size<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR36">36</xref></sup>, but the results described here remain a prime resource for studies of genetic variation for several reasons. First, the 1000 Genomes Project samples provide a broad representation of human genetic variation—in contrast to the bulk of complex disease studies in humans, which primarily study European ancestry samples and which, as we show, fail to capture functionally important variation in other populations. Second, the project analyses incorporate multiple analysis strategies, callsets and variant types. Although such ensemble analyses are cumbersome, they provide a benchmark for what can be achieved and a yardstick against which more practical analysis strategies can be evaluated. Third, project samples and data resulting from them can be shared broadly, enabling sequencing strategies and analysis methods to be compared easily on a benchmark set of samples. Because of the wide availability of the data and samples, these samples have been and will continue to be used for studying many molecular phenotypes. Thus, we predict that the samples will accumulate many types of data that will allow connections to be drawn between variants and both molecular and disease phenotypes.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary information</title>
    <p>
      <supplementary-material content-type="local-data" id="MOESM86">
        <media xlink:href="41586_2015_BFnature15393_MOESM86_ESM.pdf">
          <caption>
            <title>Supplementary Information</title>
            <p>This file contains Supplementary Methods, Supplementary References and Supplementary Tables 1-12. (PDF 4486 kb)</p>
          </caption>
        </media>
      </supplementary-material>
    </p>
  </sec>
</body>
<back>
  <app-group>
    <app id="App1">
      <sec id="Sec11">
        <title>Extended data figures and tables</title>
        <p id="Par26">
          <fig id="Fig5">
            <label>Extended Data Figure 1</label>
            <caption>
              <title>Summary of the callset generation pipeline.</title>
              <p>Boxes indicate steps in the process and numbers indicate the corresponding section(s) within the <xref rid="MOESM86" ref-type="media">Supplementary Information</xref>.</p>
            </caption>
            <graphic position="anchor" xlink:href="41586_2015_Article_BFnature15393_Fig5_ESM" id="d32e9781"/>
          </fig>
          <fig id="Fig6">
            <label>Extended Data Figure 2</label>
            <caption>
              <title>Power of discovery and heterozygote genotype discordance.</title>
              <p><bold>a,</bold> The power of discovery within the main data set for SNPs and indels identified within an overlapping sample of 284 genomes sequenced to high coverage by Complete Genomics (CG), and against a panel of &gt;60,000 haplotypes constructed by the Haplotype Reference Consortium (HRC)<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. To provide a measure of uncertainty, one curve is plotted for each chromosome. <bold>b,</bold> Improved power of discovery in phase 3 compared to phase 1, as assessed in a sample of 170 Complete Genomics genomes that are included in both phase 1 and phase 3. <bold>c,</bold> Heterozygote discordance in phase 3 for SNPs, indels, and SVs compared to 284 Complete Genomics genomes. <bold>d,</bold> Heterozygote discordance for phase 3 compared to phase 1 within the intersecting sample. <bold>e,</bold> Sensitivity to detect Complete Genomics SNPs as a function of sequencing depth. <bold>f,</bold> Heterozygote genotype discordance as a function of sequencing depth, as compared to Complete Genomics data.</p>
            </caption>
            <graphic position="anchor" xlink:href="41586_2015_Article_BFnature15393_Fig6_ESM" id="d32e9815"/>
          </fig>
          <fig id="Fig7">
            <label>Extended Data Figure 3</label>
            <caption>
              <title>Variant counts.</title>
              <p><bold>a,</bold> The number of variants within the phase 3 sample as a function of alternative allele frequency. <bold>b,</bold> The average number of detected variants per genome with whole-sample allele frequencies &lt;0.5% (grey bars), with the average number of singletons indicated by colours.</p>
            </caption>
            <graphic position="anchor" xlink:href="41586_2015_Article_BFnature15393_Fig7_ESM" id="d32e9832"/>
          </fig>
          <fig id="Fig8">
            <label>Extended Data Figure 4</label>
            <caption>
              <title>The standardized number of variant sites per genome, partitioned by population and variant category.</title>
              <p>For each category, <italic>z</italic>-scores were calculated by subtracting the mean number of sites per genome (calculated across the whole sample), and dividing by the standard deviation. From left: sites with a derived allele, synonymous sites with a derived allele, nonsynonymous sites with a derived allele, sites with a loss-of-function allele, sites with a HGMD disease mutation allele, sites with a ClinVar pathogenic variant, and sites carrying a GWAS risk allele.</p>
            </caption>
            <graphic position="anchor" xlink:href="41586_2015_Article_BFnature15393_Fig8_ESM" id="d32e9847"/>
          </fig>
          <fig id="Fig9">
            <label>Extended Data Figure 5</label>
            <caption>
              <title>Population structure as inferred using the admixture program for <italic>K</italic> = 5 to 12.</title>
            </caption>
            <graphic position="anchor" xlink:href="41586_2015_Article_BFnature15393_Fig9_ESM" id="d32e9864"/>
          </fig>
          <fig id="Fig10">
            <label>Extended Data Figure 6</label>
            <caption>
              <title>Allelic sharing.</title>
              <p><bold>a,</bold> Genotype covariance (above diagonal) and sharing of <italic>f</italic><sub>2</sub> variants (below diagonal) between pairs of individuals. <bold>b,</bold> Quantification of average <italic>f</italic><sub>2</sub> sharing between populations. Each row represents the distribution of <italic>f</italic><sub>2</sub> variants shared between individuals from the population indicated on the left to individuals from each of the sampled populations. <bold>c,</bold> The average number of <italic>f</italic><sub>2</sub> variants per haploid genome. <bold>d,</bold> The inferred age of <italic>f</italic><sub>2</sub> variants, as estimated from shared haplotype lengths, with black dots indicating the median value.</p>
            </caption>
            <graphic position="anchor" xlink:href="41586_2015_Article_BFnature15393_Fig10_ESM" id="d32e9914"/>
          </fig>
          <fig id="Fig11">
            <label>Extended Data Figure 7</label>
            <caption>
              <title>Unsmoothed PSMC curves.</title>
              <p><bold>a,</bold> The median PSMC curve for each population. <bold>b,</bold> PSMC curves estimated separately for all individuals within the 1000 Genomes sample. <bold>c,</bold> Unsmoothed PSMC curves comparing estimates from the low coverage data (dashed lines) to those obtained from high coverage PCR-free data (solid lines). Notable differences are confined to very recent time intervals, where the additional rare variants identified by deep sequencing suggest larger population sizes.</p>
            </caption>
            <graphic position="anchor" xlink:href="41586_2015_Article_BFnature15393_Fig11_ESM" id="d32e9934"/>
          </fig>
          <fig id="Fig12">
            <label>Extended Data Figure 8</label>
            <caption>
              <title>Genes showing very strong patterns of differentiation between pairs of closely related populations within each continental group.</title>
              <p>Within each continental group, the maximum PBS statistic was selected from all pairwise population comparisons within the continental group against all possible out-of-continent populations. Note the <italic>x</italic> axis shows the number of polymorphic sites within the maximal comparison.</p>
            </caption>
            <graphic position="anchor" xlink:href="41586_2015_Article_BFnature15393_Fig12_ESM" id="d32e9949"/>
          </fig>
          <fig id="Fig13">
            <label>Extended Data Figure 9</label>
            <caption>
              <title>Performance of imputation.</title>
              <p><bold>a,</bold> Performance of imputation in 6 populations using a subset of phase 3 as a reference panel (<italic>n</italic> = 2,445), phase 1 (<italic>n</italic> = 1,065), and the corresponding data within intersecting samples from both phases (<italic>n</italic> = 1,006). <bold>b,</bold> Performance of imputation from phase 3 by variant class.</p>
            </caption>
            <graphic position="anchor" xlink:href="41586_2015_Article_BFnature15393_Fig13_ESM" id="d32e9975"/>
          </fig>
          <fig id="Fig14">
            <label>Extended Data Figure 10</label>
            <caption>
              <title>Decay of linkage disequilibrium as a function of physical distance.</title>
              <p>Linkage disequilibrium was calculated around 10,000 randomly selected polymorphic sites in each population, having first thinned each population down to the same sample size (61 individuals). The plotted line represents a 5 kb moving average.</p>
            </caption>
            <graphic position="anchor" xlink:href="41586_2015_Article_BFnature15393_Fig14_ESM" id="d32e9987"/>
          </fig>
        </p>
      </sec>
      <sec id="Sec12">
        <title>Related audio</title>
        <p id="Par27">
          <media position="anchor" xlink:href="41586_2015_BFnature15393_MOESM87_ESM.mp3" id="MOESM87">
            <caption>
              <p>Adam Levy investigates the huge progress made in the 25 years since Human Genome Project began.</p>
            </caption>
          </media>
        </p>
      </sec>
      <sec id="Sec14">
        <title>PowerPoint slides</title>
        <p id="Par29">
          <media position="anchor" xlink:href="41586_2015_BFnature15393_MOESM82_ESM.ppt" id="MOESM82">
            <caption>
              <p>PowerPoint slide for Fig. 1</p>
            </caption>
          </media>
          <media position="anchor" xlink:href="41586_2015_BFnature15393_MOESM83_ESM.ppt" id="MOESM83">
            <caption>
              <p>PowerPoint slide for Fig. 2</p>
            </caption>
          </media>
          <media position="anchor" xlink:href="41586_2015_BFnature15393_MOESM84_ESM.ppt" id="MOESM84">
            <caption>
              <p>PowerPoint slide for Fig. 3</p>
            </caption>
          </media>
          <media position="anchor" xlink:href="41586_2015_BFnature15393_MOESM85_ESM.ppt" id="MOESM85">
            <caption>
              <p>PowerPoint slide for Fig. 4</p>
            </caption>
          </media>
        </p>
      </sec>
    </app>
  </app-group>
  <fn-group>
    <fn>
      <p>(Participants are arranged by project role, then by institution alphabetically, and finally alphabetically within institutions except for Principal Investigators and Project Leaders, as indicated.)</p>
    </fn>
    <fn>
      <p>Leena Peltonen: Deceased</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>We thank the many people who were generous with contributing their samples to the project: the African Caribbean in Barbados; Bengali in Bangladesh; British in England and Scotland; Chinese Dai in Xishuangbanna, China; Colombians in Medellin, Colombia; Esan in Nigeria; Finnish in Finland; Gambian in Western Division – Mandinka; Gujarati Indians in Houston, Texas, USA; Han Chinese in Beijing, China; Iberian populations in Spain; Indian Telugu in the UK; Japanese in Tokyo, Japan; Kinh in Ho Chi Minh City, Vietnam; Luhya in Webuye, Kenya; Mende in Sierra Leone; people with African ancestry in the southwest USA; people with Mexican ancestry in Los Angeles, California, USA; Peruvians in Lima, Peru; Puerto Ricans in Puerto Rico; Punjabi in Lahore, Pakistan; southern Han Chinese; Sri Lankan Tamil in the UK; Toscani in Italia; Utah residents (CEPH) with northern and western European ancestry; and Yoruba in Ibadan, Nigeria. Many thanks to the people who contributed to this project: P. Maul, T. Maul, and C. Foster; Z. Chong, X. Fan, W. Zhou, and T. Chen; N. Sengamalay, S. Ott, L. Sadzewicz, J. Liu, and L. Tallon; L. Merson; O. Folarin, D. Asogun, O. Ikpwonmosa, E. Philomena, G. Akpede, S. Okhobgenin, and O. Omoniwa; the staff of the Institute of Lassa Fever Research and Control (ILFRC), Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria; A. Schlattl and T. Zichner; S. Lewis, E. Appelbaum, and L. Fulton; A. Yurovsky and I. Padioleau; N. Kaelin and F. Laplace; E. Drury and H. Arbery; A. Naranjo, M. Victoria Parra, and C. Duque; S. Dökel, B. Lenz, and S. Schrinner; S. Bumpstead; and C. Fletcher-Hoppe. Funding for this work was from the Wellcome Trust Core Award 090532/Z/09/Z and Senior Investigator Award 095552/Z/11/Z (P.D.), and grants WT098051 (R.D.), WT095908 and WT109497 (P.F.), WT086084/Z/08/Z and WT100956/Z/13/Z (G.M.), WT097307 (W.K.), WT0855322/Z/08/Z (R.L.), WT090770/Z/09/Z (D.K.), the Wellcome Trust Major Overseas program in Vietnam grant 089276/Z.09/Z (S.D.), the Medical Research Council UK grant G0801823 (J.L.M.), the UK Biotechnology and Biological Sciences Research Council grants BB/I02593X/1 (G.M.) and BB/I021213/1 (A.R.L.), the British Heart Foundation (C.A.A.), the Monument Trust (J.H.), the European Molecular Biology Laboratory (P.F.), the European Research Council grant 617306 (J.L.M.), the Chinese 863 Program 2012AA02A201, the National Basic Research program of China 973 program no. 2011CB809201, 2011CB809202 and 2011CB809203, Natural Science Foundation of China 31161130357, the Shenzhen Municipal Government of China grant ZYC201105170397A (J.W.), the Canadian Institutes of Health Research Operating grant 136855 and Canada Research Chair (S.G.), Banting Postdoctoral Fellowship from the Canadian Institutes of Health Research (M.K.D.), a Le Fonds de Recherche du Québec-Santé (FRQS) research fellowship (A.H.), Genome Quebec (P.A.), the Ontario Ministry of Research and Innovation – Ontario Institute for Cancer Research Investigator Award (P.A., J.S.), the Quebec Ministry of Economic Development, Innovation, and Exports grant PSR-SIIRI-195 (P.A.), the German Federal Ministry of Education and Research (BMBF) grants 0315428A and 01GS08201 (R.H.), the Max Planck Society (H.L., G.M., R.S.), BMBF-EPITREAT grant 0316190A (R.H., M.L.), the German Research Foundation (Deutsche Forschungsgemeinschaft) Emmy Noether Grant KO4037/1-1 (J.O.K.), the Beatriu de Pinos Program grants 2006 BP-A 10144 and 2009 BP-B 00274 (M.V.), the Spanish National Institute for Health Research grant PRB2 IPT13/0001-ISCIII-SGEFI/FEDER (A.O.), Ewha Womans University (C.L.), the Japan Society for the Promotion of Science Fellowship number PE13075 (N.P.), the Louis Jeantet Foundation (E.T.D.), the Marie Curie Actions Career Integration grant 303772 (C.A.), the Swiss National Science Foundation 31003A_130342 and NCCR “Frontiers in Genetics” (E.T.D.), the University of Geneva (E.T.D., T.L., G.M.), the US National Institutes of Health National Center for Biotechnology Information (S.S.) and grants U54HG3067 (E.S.L.), U54HG3273 and U01HG5211 (R.A.G.), U54HG3079 (R.K.W., E.R.M.), R01HG2898 (S.E.D.), R01HG2385 (E.E.E.), RC2HG5552 and U01HG6513 (G.T.M., G.R.A.), U01HG5214 (A.C.), U01HG5715 (C.D.B.), U01HG5718 (M.G.), U01HG5728 (Y.X.F.), U41HG7635 (R.K.W., E.E.E., P.H.S.), U41HG7497 (C.L., M.A.B., K.C., L.D., E.E.E., M.G., J.O.K., G.T.M., S.A.M., R.E.M., J.L.S., K.Y.), R01HG4960 and R01HG5701 (B.L.B.), R01HG5214 (G.A.), R01HG6855 (S.M.), R01HG7068 (R.E.M.), R01HG7644 (R.D.H.), DP2OD6514 (P.S.), DP5OD9154 (J.K.), R01CA166661 (S.E.D.), R01CA172652 (K.C.), P01GM99568 (S.R.B.), R01GM59290 (L.B.J., M.A.B.), R01GM104390 (L.B.J., M.Y.Y.), T32GM7790 (C.D.B., A.R.M.), P01GM99568 (S.R.B.), R01HL87699 and R01HL104608 (K.C.B.), T32HL94284 (J.L.R.F.), and contracts HHSN268201100040C (A.M.R.) and HHSN272201000025C (P.S.), Harvard Medical School Eleanor and Miles Shore Fellowship (K.L.), Lundbeck Foundation Grant R170-2014-1039 (K.L.), NIJ Grant 2014-DN-BX-K089 (Y.E.), the Mary Beryl Patch Turnbull Scholar Program (K.C.B.), NSF Graduate Research Fellowship DGE-1147470 (G.D.P.), the Simons Foundation SFARI award SF51 (M.W.), and a Sloan Foundation Fellowship (R.D.H.). E.E.E. is an investigator of the Howard Hughes Medical Institute.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Author Contributions</title>
    <p>Details of author contributions can be found in the author list.</p>
  </notes>
  <notes notes-type="COI-statement">
    <title>Competing interests</title>
    <p id="Par25">D.M.A. is affiliated with Vertex Pharmaceuticals, E.A. is on the speaker’s bureau for Illumina, P.A. is an advisor to Illumina and Ancestry.com, D.R.B., B.B., M.B., R.K.C., A.C., M.E., S.H., S.K., L.M., J.P. and R.S. are affiliated with Illumina, J.K.B. is affiliated with Ancestry.com, A.C. is on the Science Advisory Board of Biogen Idec. and the scientific advisory board of Affymetrix, A.W.C. is affiliated with DNAnexus, D.C. is affiliated with Personalis, C.J.D., J.G., J.P.S., T.W., B.W., and Y.Z. are affiliated with Affymetrix, E.T.D. is an advisor for DNAnexus, F.M.D.L.V. is employed by Real Time Genomics, M.A.D. is affiliated with SynapDx, P.D. is a co-founder and director of Genomics, and a partner in Peptide Groove, R.D. is a founder of Congenica and a consultant for Dovetail, E.E.E. is on the scientific advisory board of DNAnexus, and is a consultant for Kunming University of Science and Technology as part of the 1000 China Talent Program, P.F. is a member of the scientific advisory board of Omicia, M.G. is an advisor to Bina and DNAnexus, F.C.L.H. is affiliated with ThermoFisher Scientific, N.H. is affiliated with Life Technologies, C.L. is a scientific advisor for BioNano Genomics, H.Y.K.L. is affiliated with Bina Technologies which is part of Roche Sequencing, E.R.M. holds shares in Life Technologies, and G.M. is a co-founder of Genomics and a partner in Peptide Groove.</p>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1</label>
      <mixed-citation publication-type="other">The 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. <italic>Nature</italic><bold>467</bold>, 1061–1073 (2010)</mixed-citation>
    </ref>
    <ref id="CR2">
      <label>2</label>
      <mixed-citation publication-type="other">The 1000 Genomes Project Consortium. An integrated map of genetic variation from 1,092 human genomes. <italic>Nature</italic><bold>491</bold>, 56–65 (2012)</mixed-citation>
    </ref>
    <ref id="CR3">
      <label>3</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Voight</surname>
            <given-names>BF</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits</article-title>
        <source>PLoS Genet.</source>
        <year>2012</year>
        <volume>8</volume>
        <fpage>e1002793</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1002793</pub-id>
        <pub-id pub-id-type="pmid">22876189</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Trynka</surname>
            <given-names>G</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease</article-title>
        <source>Nature Genet.</source>
        <year>2011</year>
        <volume>43</volume>
        <fpage>1193</fpage>
        <lpage>1201</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.998</pub-id>
        <pub-id pub-id-type="pmid">22057235</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Howie</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Fuchsberger</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Stephens</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Marchini</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Abecasis</surname>
            <given-names>GR</given-names>
          </name>
        </person-group>
        <article-title>Fast and accurate genotype imputation in genome-wide association studies through pre-phasing</article-title>
        <source>Nature Genet.</source>
        <year>2012</year>
        <volume>44</volume>
        <fpage>955</fpage>
        <lpage>959</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.2354</pub-id>
        <pub-id pub-id-type="pmid">22820512</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xue</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Deleterious- and disease-allele prevalence in healthy individuals: insights from current predictions, mutation databases, and population-scale resequencing</article-title>
        <source>Am. J. Hum. Genet.</source>
        <year>2012</year>
        <volume>91</volume>
        <fpage>1022</fpage>
        <lpage>1032</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.10.015</pub-id>
        <pub-id pub-id-type="pmid">23217326</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jung</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Bleazard</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hong</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Systematic investigation of cancer-associated somatic point mutations in SNP databases</article-title>
        <source>Nature Biotechnol.</source>
        <year>2013</year>
        <volume>31</volume>
        <fpage>787</fpage>
        <lpage>789</lpage>
        <pub-id pub-id-type="doi">10.1038/nbt.2681</pub-id>
        <pub-id pub-id-type="pmid">24022151</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8</label>
      <mixed-citation publication-type="other">Sudmant, P. H. et al. An integrated map of structural variation in 2,504 human genomes. <italic>Nature</italic>10.1038/nature15394 (this issue)</mixed-citation>
    </ref>
    <ref id="CR9">
      <label>9</label>
      <mixed-citation publication-type="other">The Haplotype Reference Consortium (<ext-link ext-link-type="uri" xlink:href="http://www.haplotype-reference-consortium.org/">http://www.haplotype-reference-consortium.org/</ext-link>)</mixed-citation>
    </ref>
    <ref id="CR10">
      <label>10</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Simons</surname>
            <given-names>YB</given-names>
          </name>
          <name>
            <surname>Turchin</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Pritchard</surname>
            <given-names>JK</given-names>
          </name>
          <name>
            <surname>Sella</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>The deleterious mutation load is insensitive to recent population history</article-title>
        <source>Nature Genet.</source>
        <year>2014</year>
        <volume>46</volume>
        <fpage>220</fpage>
        <lpage>224</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.2896</pub-id>
        <pub-id pub-id-type="pmid">24509481</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Do</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>No evidence that selection has been less effective at removing deleterious mutations in Europeans than in Africans</article-title>
        <source>Nature Genet.</source>
        <year>2015</year>
        <volume>47</volume>
        <fpage>126</fpage>
        <lpage>131</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.3186</pub-id>
        <pub-id pub-id-type="pmid">25581429</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Alexander</surname>
            <given-names>DH</given-names>
          </name>
          <name>
            <surname>Novembre</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lange</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Fast model-based estimation of ancestry in unrelated individuals</article-title>
        <source>Genome Res.</source>
        <year>2009</year>
        <volume>19</volume>
        <fpage>1655</fpage>
        <lpage>1664</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.094052.109</pub-id>
        <pub-id pub-id-type="pmid">19648217</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mathieson</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>McVean</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Demography and the age of rare variants</article-title>
        <source>PLoS Genet.</source>
        <year>2014</year>
        <volume>10</volume>
        <fpage>e1004528</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1004528</pub-id>
        <pub-id pub-id-type="pmid">25101869</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Durbin</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Inference of human population history from individual whole-genome sequences</article-title>
        <source>Nature</source>
        <year>2011</year>
        <volume>475</volume>
        <fpage>493</fpage>
        <lpage>496</lpage>
        <pub-id pub-id-type="doi">10.1038/nature10231</pub-id>
        <pub-id pub-id-type="pmid">21753753</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Moltke</surname>
            <given-names>I</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A common Greenlandic <italic>TBC1D4</italic> variant confers muscle insulin resistance and type 2 diabetes</article-title>
        <source>Nature</source>
        <year>2014</year>
        <volume>512</volume>
        <fpage>190</fpage>
        <lpage>193</lpage>
        <pub-id pub-id-type="doi">10.1038/nature13425</pub-id>
        <pub-id pub-id-type="pmid">25043022</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yi</surname>
            <given-names>X</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Sequencing of 50 human exomes reveals adaptation to high altitude</article-title>
        <source>Science</source>
        <year>2010</year>
        <volume>329</volume>
        <fpage>75</fpage>
        <lpage>78</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1190371</pub-id>
        <pub-id pub-id-type="pmid">20595611</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lamason</surname>
            <given-names>RL</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>SLC24A5, a putative cation exchanger, affects pigmentation in zebrafish and humans</article-title>
        <source>Science</source>
        <year>2005</year>
        <volume>310</volume>
        <fpage>1782</fpage>
        <lpage>1786</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1116238</pub-id>
        <pub-id pub-id-type="pmid">16357253</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Eiberg</surname>
            <given-names>H</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Blue eye color in humans may be caused by a perfectly associated founder mutation in a regulatory element located within the <italic>HERC2</italic> gene inhibiting <italic>OCA2</italic> expression</article-title>
        <source>Hum. Genet.</source>
        <year>2008</year>
        <volume>123</volume>
        <fpage>177</fpage>
        <lpage>187</lpage>
        <pub-id pub-id-type="doi">10.1007/s00439-007-0460-x</pub-id>
        <pub-id pub-id-type="pmid">18172690</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mathias</surname>
            <given-names>RA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Adaptive evolution of the <italic>FADS</italic> gene cluster within Africa</article-title>
        <source>PLoS ONE</source>
        <year>2012</year>
        <volume>7</volume>
        <fpage>e44926</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0044926</pub-id>
        <pub-id pub-id-type="pmid">23028684</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hernandez</surname>
            <given-names>RD</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Classic selective sweeps were rare in recent human evolution</article-title>
        <source>Science</source>
        <year>2011</year>
        <volume>331</volume>
        <fpage>920</fpage>
        <lpage>924</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1198878</pub-id>
        <pub-id pub-id-type="pmid">21330547</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>W</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genetic variants near <italic>TIMP3</italic> and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration</article-title>
        <source>Proc. Natl Acad. Sci. USA</source>
        <year>2010</year>
        <volume>107</volume>
        <fpage>7401</fpage>
        <lpage>7406</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.0912702107</pub-id>
        <pub-id pub-id-type="pmid">20385819</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wakefield</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Bayes factors for genome-wide association studies: comparison with <italic>P</italic>-values</article-title>
        <source>Genet. Epidemiol.</source>
        <year>2009</year>
        <volume>33</volume>
        <fpage>79</fpage>
        <lpage>86</lpage>
        <pub-id pub-id-type="doi">10.1002/gepi.20359</pub-id>
        <pub-id pub-id-type="pmid">18642345</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wakefield</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Commentary: genome-wide significance thresholds via Bayes factors</article-title>
        <source>Int. J. Epidemiol.</source>
        <year>2012</year>
        <volume>41</volume>
        <fpage>286</fpage>
        <lpage>291</lpage>
        <pub-id pub-id-type="doi">10.1093/ije/dyr241</pub-id>
        <pub-id pub-id-type="pmid">22345299</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sham</surname>
            <given-names>PC</given-names>
          </name>
          <name>
            <surname>Purcell</surname>
            <given-names>SM</given-names>
          </name>
        </person-group>
        <article-title>Statistical power and significance testing in large-scale genetic studies</article-title>
        <source>Nature Rev. Genet.</source>
        <year>2014</year>
        <volume>15</volume>
        <fpage>335</fpage>
        <lpage>346</lpage>
        <pub-id pub-id-type="doi">10.1038/nrg3706</pub-id>
        <pub-id pub-id-type="pmid">24739678</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gold</surname>
            <given-names>B</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Variation in factor B (<italic>BF</italic>) and complement component 2 (<italic>C2</italic>) genes is associated with age-related macular degeneration</article-title>
        <source>Nature Genet.</source>
        <year>2006</year>
        <volume>38</volume>
        <fpage>458</fpage>
        <lpage>462</lpage>
        <pub-id pub-id-type="doi">10.1038/ng1750</pub-id>
        <pub-id pub-id-type="pmid">16518403</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Klein</surname>
            <given-names>RJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Complement factor H polymorphism in age-related macular degeneration</article-title>
        <source>Science</source>
        <year>2005</year>
        <volume>308</volume>
        <fpage>385</fpage>
        <lpage>389</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1109557</pub-id>
        <pub-id pub-id-type="pmid">15761122</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rivera</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Hypothetical <italic>LOC387715</italic> is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk</article-title>
        <source>Hum. Mol. Genet.</source>
        <year>2005</year>
        <volume>14</volume>
        <fpage>3227</fpage>
        <lpage>3236</lpage>
        <pub-id pub-id-type="doi">10.1093/hmg/ddi353</pub-id>
        <pub-id pub-id-type="pmid">16174643</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yates</surname>
            <given-names>JR</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Complement C3 variant and the risk of age-related macular degeneration</article-title>
        <source>N. Engl. J. Med.</source>
        <year>2007</year>
        <volume>357</volume>
        <fpage>553</fpage>
        <lpage>561</lpage>
        <pub-id pub-id-type="doi">10.1056/NEJMoa072618</pub-id>
        <pub-id pub-id-type="pmid">17634448</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Maller</surname>
            <given-names>JB</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Bayesian refinement of association signals for 14 loci in 3 common diseases</article-title>
        <source>Nature Genet.</source>
        <year>2012</year>
        <volume>44</volume>
        <fpage>1294</fpage>
        <lpage>1301</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.2435</pub-id>
        <pub-id pub-id-type="pmid">23104008</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fritsche</surname>
            <given-names>LG</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Age-related macular degeneration is associated with an unstable <italic>ARMS2</italic> (<italic>LOC387715</italic>) mRNA</article-title>
        <source>Nature Genet.</source>
        <year>2008</year>
        <volume>40</volume>
        <fpage>892</fpage>
        <lpage>896</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.170</pub-id>
        <pub-id pub-id-type="pmid">18511946</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31</label>
      <mixed-citation publication-type="other">The ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. <italic>Nature</italic><bold>489</bold>, 57–74 (2012)</mixed-citation>
    </ref>
    <ref id="CR32">
      <label>32</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Stranger</surname>
            <given-names>BE</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Patterns of <italic>cis</italic> regulatory variation in diverse human populations</article-title>
        <source>PLoS Genet.</source>
        <year>2012</year>
        <volume>8</volume>
        <fpage>e1002639</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1002639</pub-id>
        <pub-id pub-id-type="pmid">22532805</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chaisson</surname>
            <given-names>MJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Resolving the complexity of the human genome using single-molecule sequencing</article-title>
        <source>Nature</source>
        <year>2015</year>
        <volume>517</volume>
        <fpage>608</fpage>
        <lpage>611</lpage>
        <pub-id pub-id-type="doi">10.1038/nature13907</pub-id>
        <pub-id pub-id-type="pmid">25383537</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gudbjartsson</surname>
            <given-names>DF</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Large-scale whole-genome sequencing of the Icelandic population</article-title>
        <source>Nature Genet.</source>
        <year>2015</year>
        <volume>47</volume>
        <fpage>435</fpage>
        <lpage>444</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.3247</pub-id>
        <pub-id pub-id-type="pmid">25807286</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35</label>
      <mixed-citation publication-type="other">The UK10K Consortium. The UK10K project identifies rare variants in health and disease. <italic>Nature</italic>10.1038/nature14962 (2015)</mixed-citation>
    </ref>
    <ref id="CR36">
      <label>36</label>
      <mixed-citation publication-type="other">Sidore, C. et al. Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers. <italic>Nature Genet.</italic>10.1038/ng.3368 (2015)</mixed-citation>
    </ref>
    <ref id="CR37">
      <label>37</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Delaneau</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Marchini</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>The 1000 Genomes Project Consortium. Integrating sequence and array data to create an improved 1000 Genomes Project haplotype reference panel</article-title>
        <source>Nature Commun.</source>
        <year>2014</year>
        <volume>5</volume>
        <fpage>3934</fpage>
        <pub-id pub-id-type="doi">10.1038/ncomms4934</pub-id>
        <pub-id pub-id-type="pmid">25653097</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>O’Connell</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A general approach for haplotype phasing across the full spectrum of relatedness</article-title>
        <source>PLoS Genet.</source>
        <year>2014</year>
        <volume>10</volume>
        <fpage>e1004234</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1004234</pub-id>
        <pub-id pub-id-type="pmid">24743097</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Menelaou</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Marchini</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Genotype calling and phasing using next-generation sequencing reads and a haplotype scaffold</article-title>
        <source>Bioinformatics</source>
        <year>2013</year>
        <volume>29</volume>
        <fpage>84</fpage>
        <lpage>91</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bts632</pub-id>
        <pub-id pub-id-type="pmid">23093610</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
